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1. Abstract 
Context factors have been hypothesized as being a core element in the medical treatment of 
the patient. Although their importance has extensively been described with regard to the 
medical and psychotherapeutic treatment, the empirical evidence of two factors, trust in the 
provider and meaning transformation in a treatment, remains vague. In order to study these 
two factors we used a two-folded approach: 1) A meta-analysis, quantifying the impact of 
trust on the health outcome and 2) the development of two experimental paradigms in order to 
provide a tool to systematically manipulate trust in provider and meaning transformation in 
order to test for their influence in research and clinical practice. 
To quantify the impact of interpersonal trust in the clinical setting a meta-analysis was 
undertaken. Therefore, 5667 studies were screened. An overall mean effect as well as effect 
sizes for different subtypes of health outcomes were calculated. Patients reported higher 
treatment satisfaction, more beneficial health behaviors, less symptoms and a higher quality 
of life if they trusted their health care professional. With regard to objective health outcomes 
no direct link to trust was detectable with trust. 
In a second step we tested the validity and feasibility of two placebo designs in order 
to study context factors in an empirical design. First, the effect of opposing therapy rationales 
was tested, using an open/hidden administration of an expressive writing intervention. The 
linguistic content analysis indicated plausibiliy of the experimental manipulation for the 
participants. Moreover, participants in the openly administered condition benefited from the 
expressive writing intervention in the long-run.  
In the second experiment, we tested if the trust game, often used in economic 
psychology, might be a tool to induce trust for medical research. Therefore we used two fixed 
trust conditions. Randomly, half of the participants were allocated to the trust condition, 
implying a trustful participant-investigator-relationship, while the other half was distributed to 
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a non-trustful condition. We found that trust could systematically be manipulated, even 
controlling for emotions as anger or anxiety. The subjective rating of trust differed from the 
behavioral response of the participant. 
Overall, these three papers try to contribute to a developing research on context 
factors. Mainly, I want to shed attention on two factors: trust in the provider and meaning 
transformation, which are less understood and tested in research. Rather than providing a 
theoretical debate on this topic, this dissertation aims to give an empirical insight and suggests 
two paradigms to elaborate research on this field. To quantify the mostly untested effects on 
trust and meaning transformation might be particular important in regard to a cost-benefit 
oriented health care policy. 
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2. Introduction 
2.1 Context factors in medicine and psychotherapy 
Patients are treated in a social and psychophysiological environment in which the interaction 
of the doctor and the patient is of high importance for the subjective as well as for physical 
health outcome (Spiegel & Harrington, 2008). In the health care setting, a situation that is 
mainly characterized by uncertainty, even well informed patients have to rely on the health 
care professional to work in their best interest (M. Calnan & Rowe, 2006). With regard to 
placebo research it has been shown that unspecific factors such as the patient-provider 
relationship as well as the treatment characteristics (e.g. the size of a tablet and especially the 
treatment rational) seem to play a major role for the treatment outcome (Di Blasi, Harkness, 
Ernst, Georgiou, & Kleijnen, 2001). For psychotherapy more than for medical treatments, 
Frank (1986) has postulated that effects on the outcome have been found to result from the 
transformation of meaning that clients attach to their symptoms, relationships and life 
problems (Frank, 1986). Frank (1986) states that the key to healing is the elimination of the 
social isolation through supporting personal relationships and the transformed meaning 
patients attribute to their experiences and certain events. The transformation of meaning 
thereby involves an confiding relationship with a healer, a healing setting, a conceptual 
scheme or rationale, and procedures that both the healer and patient believe in and that 
involve active participation and positive expectations for change (Eysenck, 1994; Wampold, 
2007a).  
In this context, several authors have argued that the important component of meaning 
transformation is not to find the truth itself, but rather the formation of a new explanation that 
is plausible and adaptive - a coherent understanding of the world of the patient (Frank, 1986; 
Kazdin, 2007; Wampold, 2007b). This idea has been supported by a study showing that 
opposing breathing therapies result in the same effect as long as both therapies have a 
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comprehensive therapy rational (Sunyoung Kim, Eileen Wollburg, Walton T. Roth, 2012). 
One might conclude, that the rational therefore does not need to be of a specific content but 
rather has to be coherent in its own. Wampold supports this hypothesis by referring to the 
changing healing practices and their accompanying explanations, which are generated by the 
prevailing metaphysical zeitgeist of a particular society (Wampold, 2007b). However, 
empirical evidence for the effects of meaning transformation in psychotherapy is still lacking. 
With regard to a second significant context factor, the effect of the patient provider 
relationship, Hippocrates described 400BC: “The patient, though conscious that his condition 
is perilous, may recover his health simply through his contentment with the goodness of the 
physician” (Di Blasi et al., 2001). Indeed, a study conducted by Kaptchuck and colleagues 
(2008) outlined that the effect sizes of combined outcome measures in a trial of placebo 
acupuncture in irritable bowel syndrome increased about 100% when the practitioner engaged 
in a warm and empathetic interaction with patients (Kaptchuk et al., 2008). Moreover, a meta-
analysis by Kelley and colleagues (2014) found a small but significant effect of the 
relationship on the treatment outcome (Kelley, Kraft-Todd, Schapira, Kossowsky, & Riess, 
2014). While the importance of the patient provider relationship is generally established in 
research, evidence and research is lacking for more specific factors, such as trust in the doctor. 
The General Medical Council has declared the trustful relationship with the patient as 
a major duty of the doctor (General Medical Council). Besides its value per se, Blackstock 
and colleagues (2012) found that high trust in the clinical encounter was significantly 
associated with increased odds of antiretroviral adherence. They postulated the improvement 
of the trust level as a major implication for treatment (Blackstock, Addison, Brennan, & Alao, 
2012). In accordance with these results, Hillen and colleagues (2011) concluded that a trustful 
relationship with the doctor resulted in a facilitated communication and a more efficient 
medical decision making process, a decrease of patient fear as well as an increased treatment 
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adherence and in the end resulting in a better health outcome of the patient (Hillen, de Haes, 
& Smets, 2011).  
Although trust has been empirically studied in economics (Johnson & Mislin, 2011) 
and in neuroscience as well as in studies (Dunn & Schweitzer, 2005; Koscik & Tranel, 2011) 
on the hormone oxytocin (Kessner, Sprenger, Wrobel, Wiech, & Bingel, 2013) no consensus 
on generally valid factors and mechanisms underlying the trust – health relationship have 
been found. To date, neither a global valid operationalization of the concept, nor an 
experimental approach of interpersonal trust can be found. For this dissertation the following 
definition of interpersonal trust has been fixed, although being aware that no “true” definition 
exists: “Trust in the physician is a patient's optimistic acceptance of a vulnerable situation, 
based on the expectation that the physician will act in the patient's best interest” (cited from 
Lee & Lin, 2009, p. 1060). 
2.1 Testing for context factors in research 
In order to systematically test and control for context factors in medical settings and in 
psychotherapy, specified paradigms need to be elaborated. As mentioned before experimental 
evidence drawn from prospective studies and randomized controlled trials are lacking for 
these factors. 
With regard to trust, the trust game by Berg, Dickhaut and McCabe (1995) is a well-
elaborated and replicated method in the domain of economic psychology, to measure trust in 
an experimental setting, including the sequential momentary exchange of two parties, with no 
predefined contract or agreement (Johnson & Mislin, 2011). There have been two variations 
of the trust game: 1.) the participant plays the trust game with a computer or 2.) with a 
randomly matched (sometimes anonymous) partner. However, to coherently test and study 
trust in a clinical setting, two changes might be necessary: 1.) trust needs to be induced 
systematically, by a standardized exchange and 2.) the trust induction must take place with a 
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doctor or therapist, which is not anonymous and not randomly matched, but has certain 
specific characteristics and acts in a particular professional frame. These changes, however, 
lead to a far fuzzier frame, potentially leading to different results from those in economic 
research. Therefore we tested whether it is possible to apply the trust game to induce trust in a 
participant by a predefined pattern in a non-anonymous investigator.  
To test for meaning transformation in psychotherapy a similar issue arises. Whereas in 
biomedical research the "double blind technique" of randomized placebo controlled trials is 
considered to test for specific effects, this approach is not applicable to psychotherapy 
(Beecher, 1955a). Some attempts have been made to solve this problem (Chambless & 
Hollon, 1998; Grunbaum, 1981), all of them accompanying their own problems (Baskin, 
Tierney, Minami, & Wampold, 2003; C. L. S. H. J. Gaab, 2016; Kazdin & Wilcoxon, 1976). 
For instance with regard to systematic desensitization (SD), Locher et al. (2016) found that 
the restriction of therapeutic topics and of the emotional experience in the control condition 
appeared to be a prerequisite to find specific effects of the SD. 
With regard to these results, the open versus hidden design might provide a tool to 
systematically test for the “meaning effects” of a treatment. In this paradigm an intervention 
is given openly (the participant knows when the drug is administered) and hidden (the 
participant does not know when the drug is given). This trial design has been used in non-
pharmacological interventions (e.g. (Crum & Langer, 2007; Desharnais, Jobin, Cote, 
Levesque, & Godin, 1993) in order to specify effects resulting from the therapeutic meaning 
of a treatment (Moerman & Jonas, 2002). However, so far this paradigm it has not been tested 
for psychotherapeutic interventions. We therefore tested the feasibility of an open versus 
hidden design for psychotherapy.  
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3. Aims of the thesis 
Context factors are key components in therapeutic as well as in medical interventions. 
However, their particular role remains unclear. Therefore, the current Ph.D. focuses on two 
context factors, interpersonal trust and meaning, and aims to measure their effects in the 
health care context as well as to develop a sophisticated and scientifically coherent design to 
study these factors in research. A meta-analysis was undertaken, to quantify the effect of 
interpersonal trust. In a second step, the two mentioned context factors were investigated with 
the help of placebo research, constructing two novel paradigms to change the meaning of a 
treatment and the trust level of the provider in a systematic manner. By this procedure, we 
aimed to provide a first experimental approach to empirically investigate these two factors.   
4. Methods 
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4. Methods 
The following section briefly introduces the study designs.  
4.1 Meta-analysis: Study 1.  Trust and health outcome 
4.1.2 Procedure and materials 
A systematic literature searches in CINAHL, Embase, MEDLINE and PsychINFO was 
conducted. We included studies that were (1) empirical and (2) reported quantitative data on 
the association between trust in the health care professional and health-related outcomes 
(exclusion of case vignettes, interviews, reviews, etc.), (3) took place in a health care setting, 
(4) were written in English or German, (5) were published journal articles and (6) measured 
interpersonal trust with a valid, reliable and established trust questionnaire. Two researcher 
independently extracted correlations between trust in the health care provider and health-
related outcomes whenever reported. 
4.1.3 Data analysis 
Extracted data was converted to correlation with corresponding 95% confidence intervals 
(95% CI). As we expected considerable heterogeneity we performed a random-effects rather 
than a fixed-effects model. Data management and analysis (calculation of mean effect size) 
was performed by the help of Comprehensive Meta–analysis program (CMA).  
4.2 Experimental studies: Study 2. Meaning – open/hidden evaluation 
4.2.1 Participants 
Overall, two samples were analyzed (completers N=112 and ITT N=126). Subjects were recruited 
amongst psychology students at two Swiss Universities (University of Zurich and University 
of Basel) through mailing lists and web postings at both universities. Inclusion criteria were 
(1)  ages of 18 years and older, (2) absence of any mental disorder by self report, (3) not 
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receiving psychological or psychiatric or medical treatment in the last six month by self-
report and (4) a Toronto Alexithymia Scale score below 54 (Kupfer, Brosig, & Brahler, 
2000), since alexithymia has been shown to influence effects of expressive writing (Paez, 
Velasco, & Gonzalez, 1999; Solano, Donati, Pecci, Persichetti, & Colaci, 2003). 
4.2.2 Procedure and materials 
The study encompassed three intervention days (days 1 to 3) and four assessments (days 1, 4, 
10, and 46, or baseline, post intervention, mid-term, and long-term follow-up, respectively). 
On intervention and assessment days, participants received an email with access to a webpage 
differing in content according to group assignment and study day. For intervention groups, on 
top of the outcome measure, the website contained an embedded video, showing a 
professional speaker explaining the rationale of the intervention. The instruction was equal for 
both intervention groups in terms of structure and format. The treatment rationale, however, 
differed in content between these groups. For the control group, the website contained the 
outcome only. The study was approved by the institutional review board of the Department of 
Psychology of the University of Basel. 
Questionnaires 
Influence on affect of the experimental conditions was repeatedly assessed with the Positive 
and Negative Affect Schedule (PANAS) (Krohne, Egloff, Kohlmann, & Tausch, 1996; 
Watson, Clark, & Tellegen, 1988). The PANAS contains two scales with overall 10 five-point 
items assessing positive (e.g. "interested", "proud") and negative affect (e.g. "upset", 
"ashamed").  
In the intervention groups, linguistic content of written text, subjective rating of the 
severity of the reported traumatic experiences and the plausibility of their respective treatment 
rationale were employed to assess the validity of the intervention and experimental 
manipulation of treatment rationale. The linguistic content of the written text was analyzed 
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with Linguistic Inquiry and Word Count (Pennebaker et al., 2001; Wolf et al., 2008), which 
reliably quantifies words in a given text according to preset categories. Subjective rating of 
the severity of the traumatic experiences was assessed with a single sentence 5-point item (i.e. 
In general, how distressing is the experience you have just written about for you?) and 
plausibility of the treatment rationale was operationalized with a 5-point item for each group 
(causality group: Writing about a traumatic experience influences my well-being, reversed 
causality group: My well-being influences how I write about a traumatic experience).  
4.2.3 Data analysis 
A time by group by scale multivariate analysis of variance with subsequent time by group 
univariate analysis of variance for single PANAS scales was used to investigate differences 
between groups regarding treatment effects over time. Analysis of variance or chi-square tests 
were used to examine demographic and clinical variables at baseline. Statistical analysis was 
performed using IBM SPSS Statistics Version 22 and significance level was set to .05. 
4.3 Experimental study: Trust induction 
4.3.1 Participants 
106 male participants were enrolled in the current study (mean age = 24.5 years, SD = 4.7 
years). Participants were recruited by advertisement at the University of Basel, via the online 
recruitment system of the department of psychology (BAPS-Sona, http://baps.sona-
systems.com) and on the website: markt.unibas.ch. We included (1) healthy (2) male students 
((3)age 18- 40) with (4) sufficient German language skills. 
4.3.2 Procedure and materials 
Trust Game 
The participants were told they were going to play a cognitive task where they could win 
some additional money, but instead played a trust game, adapted from Berg, Dickhaut and 
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McCabe (1995). Some changes were made in order to manipulate the participant’s level of 
trust. Starting with an endowment of one start unit in each sequence, the participant could 
decide to send a particular portion of their endowment to the investigator. In total, five 
sequences were played. In sequence 1 and 2, the participant could send 25%, 50% or 75 % of 
their endowment; while in sequence 3, 4 and 5 also 0 or 100 % could be send. After the 
participant sent the money, the amount was tripled. The investigator (in the role of the trustee) 
in return passed the predefined amount of money back. 
In the non-trust condition the investigator returned 50%, 0%, 25%, 0% and 0% of send 
amount respectively. With regard to the trust condition, based on the fairness heuristic, that 
trust should be facilitated when the decision yields maximum rewards for both parties, the 
experimenter always returned 50% in order to create a fair exchange (Burks, Carpenter, & 
Verhoogen, 2003). The amount passed by the sender was defined to capture trust.  
Questionnaires 
The State-Trait-Anxiety-Inventory (STAI) was employed before and after the trust game to 
measure anxiety. The STAI is a standardized self-report questionnaire, measuring anxiety 
both as state (X1) as well as a trait (X2). Both scales contain 20 items and a four-point 
ranking scale, ranging from 1 = almost never to 4 = almost always. Cronbach’s alpha for both 
scales is found to be α = .90 (Laux, 1981). Negative items were recoded.  
Also, we used the State-Trait-Anger-Expression-Inventory (STAXI) before and after 
the trust game, which assesses five subscales of anger: state anger (10 items), trait anger (10 
items), and anger expression (24 items). Items are rated on a four-point ranking scale from 1 
= not at all to 4 = very much. A median Cronbach alpha coefficient of .87 for the STAXI has 
been reported, ranging from .75 to .82 for the different scales (Spielberger & Reheiser, 2009). 
As a subjective measure of trust, participants were asked to indicate how trustful they 
perceived the investigator on a 10 cm adapted visual analogue scale (Lund, Vase, Petersen, 
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Jensen, & Finnerup). The intensity scale ranged from 0 (no trust) to 100 (high trust). Higher 
scores indicated higher trust. 
4.3.3 Data analysis 
We conducted an analysis of covariance (ANCOVA), including trust-condition as the fixed 
factor and the baseline trust measurement as the covariate. In a second step, the STAI- and 
STAXI-scores were included as covariates in order to control for the induction of anger or 
anxiety. To test whether the trust condition was also associated with differences in the amount 
sent by the participant, we calculated separate chi-square tests as an explanatory analysis. 
Statistical analysis was performed using IBM SPSS Statistics Version 22. To verify 
the normality, linearity, (if AE) and homoscedasticity assumption of the residuals, scatter-, 
box- and QQ-plots were inspected and checked for outliers (leverage, cook’s distance and 
mahalanobis distance). One subject was excluded. For all tests the significance level was set 
to .05. 
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5. Summary of results 
5.1 Trust in the health care professional and health outcome: A meta-analysis 
Results of Study 1 showed a significant association between trust in the health care 
professional and health outcome. However, results differed with regard to the outcome 
dimension, with small and non-significant correlations for objective and observer-rated 
outcomes and a moderate association with self-rated subjective outcomes. Patients reported to 
be more satisfied with treatment, to show more beneficial health behaviors, less symptoms 
and higher quality of life when they had more trust in their health care professional. With 
regard to the conducted meta-regressions, the association between trust and outcome was 
smaller in high quality studies. Interestingly, the observed association between trust and 
health appeared to be smaller in North America and Asia compared to Europe and Australia. 
Moreover, we found a larger association in studies that reported correlations and a lower 
association in studies that reported binary data.  
 
5.2 Meaning – open/hidden evaluation  
Both the intervention as well as the experimental manipulation proved valid and feasible, as 
indicated by the linguistic content analysis. The two groups did not differ substantially in their 
ratings of the treatment plausibility and indicated comparable severity of the traumatic 
experiences. 
PANAS scores did not change and groups did not differ significantly over time for 
short and mid-term effects. However, groups differed in the long-term: After six weeks both 
intervention groups benefitted with higher positive affect in comparison to the no-treatment 
control group. With regard to negative affect, the causality group showed a decrease, while 
the reversed causality group did not benefit from the intervention.  
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5.3 Trust induction 
Results of study 3 showed that the trust in the experimenter could be systematically 
manipulated by an adaptation of the trust game. Controlling for the baseline trust ratings, 
participants in the trust condition rated the experimenter as significantly more trustworthy at 
the post-rating than participants in the non-trust condition. Including anger and anxiety in the 
model this effect was attenuated but still detectable. For behavioral response, results showed a 
difference between trust conditions in round three, after the trustors' behavior was 
experimentally manipulated. Participant invested significantly more in the trust condition. For 
round four and five no difference could be detected between non-trust and trust. Moreover, 
analysis revealed a correlation between the subjective trust rating (post measure) and the 
investment in round three. No association was found for round four and five. 
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6. Discussion 
The aim of this thesis was to study two context factors: trust in the provider and the meaning 
transformation in treatment. To provide an empirical estimate of the association between trust 
in the health care professional and health outcome we conducted a meta-analysis (study 1). 
With regard to psychotherapy research, the feasibility of an open/hidden paradigm (meaning 
transformation) (study 2), and of an experimental trust induction was tested (study 3), in order 
to provide a tool to systematically study those two context factors in health care research. 
In study 1, we observed a significant association between trust in the health care professional 
and health outcome. Study 2 and study 3 presented two paradigms, which might provide a 
possible approach to further elaborate context factors in different settings. Our results show 
that the two context factors, trust and meaning transformation, have significant effects on the 
outcome of the treatment. Quantifying the effects of these factors might lead to a realization 
of their importance and as a consequence highlights the need for their preservation and 
enhancement in an evidence based and cost focused health care systems. 
6.1 Trust and health outcome 
We found a significant association between trust in the health care provider and health 
outcome, which quantifies the postulated importance of trust in health care (Benedetti, 2013; 
Brown & Calnan, 2012; Michael Calnan & Rowe, 2008; General Medical Council).  
The non-significant association between trust and objective health outcomes in our 
meta-analyses might reflect an absence of such an association. However, since we observed a 
significant correlation between trust and self-rated subjective outcomes, which in turn have 
been associated with objective outcomes (Detmar, Muller, Schornagel, Wever, & Aaronson, 
2002; Doyle, Lennox, & Bell, 2013; Simpson et al., 2006), it could also be hypothesized that 
a possible association between trust and objective outcomes depends on subjective variables, 
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such as adherence to medication or patient satisfaction with treatment (Giordano & 
Lindstrom, 2016; Street, Makoul, Arora, & Epstein, 2009).  
The differential association for the subjective and objective outcomes —i.e. larger 
associations for the self-rated subjective outcomes and a small and non-significant association 
for objective outcomes—reflects previous findings on the two outcome dimension therefore 
was expected ((Beecher, 1955b; Hrobjartsson & Gotzsche, 2010; Schwarz & Buchel, 2015; 
Wechsler et al., 2011).  
Subgroup analysis revealed a larger association in studies that reported correlations 
and a lower association in studies that reported binary data. With regard to the differences 
between the observed trust-outcome associations in Europe, North America, Australia, and 
Asia, our results are in part reflected in a recent survey on trust in physicians (Blendon, 
Benson, & Hero, 2014), Blendon and colleagues found that on a country list the US for 
instance near the bottom if asked whether they trust in their physician. However, with regard 
to satisfaction with the medical treatment the U.S. ranks near the top. In contrast, Switzerland 
is number one on both scales. This difference is in accordance with the correlations we found: 
a smaller correlation between trust in the provider and health outcome in North America than 
in Europe. 
6.2 Meaning transformation by the use of an expressive writing paradigm 
The results of the causality group reflected previous findings on expressive writing with a 
temporally delayed and medium-sized improvement in affect (Baikie, Geerligs, & Wilhelm, 
2012; Beyer et al., 2014; Langens & Schuler, 2005, 2007a). 
In line with the observed differences between the intervention groups, a recent within-
subject placebo design observed a significantly higher analgesic effect for an overt in contrast 
to a covert administration of lidocaine injections (Lund et al., 2014) – showing that even 
medical parameters can be influenced by meaning. The observed effects of our trial support the 
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feasibility and utility of an open/hidden administration to disentangle effects of meaning 
transformation. In this regard, the beneficial effects on positive affect in both intervention groups 
could be seen as being caused by characteristic constituents of expressive writing, while the incidental 
treatment constituent of providing a treatment rationale is needed to obtain full effects, i.e. beneficial 
changes in both positive and negative affect. 
6.3 Trust induction by an adaptation of the trust game 
Despite the observed significant drop in both subjective as well as in behavioral trust 
measures after the trust manipulation, our results also indicate that a certain amount of trust 
resists even in the presence of unexpected behavior of the trustor. This resistance was 
apparent for both - the subjective experience of trust as well as for the behavioral level: 
Participants investigated more than 50% in each round independent from their condition. In 
line with our findings a study by Burnham and colleagues (2000) revealed that participants 
still sent money in the distrust condition. When looking at the history of trust research these 
results become clearer. Early social psychology has defined trust as a static phenomenon, 
where the participant either completely trusts or distrusts the counterpart (Rousseau, 1998). 
However, this view has been challenged when the development of trust (including phases of 
distrust as a part of trust development) was addressed for instance by Lewicki (Lewicki, 
Tomlinson, & Gillespie, 2006). Our results support the idea that trust is not an all-or-none 
phenomena but more a continuum, where both trust and distrust might appear together.  
Also, we found that the subjective experience of trust did not correspond with the 
behavioral response in round four and five. Also, we did not find a difference between trust 
and non-trust condition with regard to investment. Moreover there was no correlation between 
trust rating and investment for round four and five. Glaeser and colleagues (2000) reported 
that behavior in the trust game was predicted by past trusting behavior and not by the 
responses of the participant on a – albeit attitudinal – trust survey. Based on this idea, it might 
hypothesized whether we judge a person as trustworthy might be independent on how we 
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react on this judgment, questioning at last partly whether a behavioral response can measure 
the perception of trustworthiness in appropriate way. Also, the lack of a correlation might 
represent a truly existing dissociation between the trust perception and the trust behavior. 
With regard to this hypothesis caution might be warranted when equalizing the investment 
(trust behavior) as a measure of trust experience in the trust game (Johnson & Mislin, 2011). 
6.4 Limitations 
Several limitations of our studies need to be considered. For the meta-analysis, there are 
indications that our overall results may be overestimated, since the significant Egger’s test 
indicates a lack of small-scaled studies with non-significant correlations. This is supported by 
the fact that we found smaller associations in higher quality studies as well as in larger 
studies. The large fail-safe N in our analysis indicated, however, a very low risk for a non-
significant overall association.  
Second, the observed large associations between trust and subjective health outcome 
we found in our results could be explained by proximity between the two concepts (Hall, 
Dugan, Zheng, & Mishra, 2001; Thom, Ribisl, Stewart, Luke, & Phys, 1999). Data from a 
large-scale survey empirically confirms an association between trust in the health care 
professional and subjective health outcome (Croker et al., 2013). However, since different 
meta-analyses describe an enhanced risk of bias with regard to self-rated subjective outcomes, 
the found association in our analyses may result at least partially from an upward bias 
(Moustgaard, Bello, Miller, & Hrobjartsson, 2014; Wood et al., 2008). Third, we could not 
satisfactorily estimate the impact of possible moderators. Classification of patient 
characteristics was not possible, since most samples were mixed with respect to potentially 
relevant factors (e.g. ethnicity or disorder). However, statistical heterogeneity was small to 
moderate, which indicates only a small risk for the presence of strong moderators. Finally, it 
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needs to be noted that our analyses does not allow any predictions on causality of the 
observed association between trust in the health care professional and health outcome.  
Also our experimental studies have distinct limitations, which need to be considered 
critically. In the open/hidden evaluation the participants in the reverse causality group may 
have known about the beneficial effects of writing. However, we opted against a direct 
inquiry, because asking participants about their assumptions regarding possibly positive 
effects of writing might prime such assumptions. Instead we assessed the plausibility of the 
respective condition rationale, which did not differ between the intervention groups. Second, 
in the open administration of the intervention we provided a description of expected positive 
effects of the intervention. Therefore, our instructions differed from those in Pennebaker 
(2000). However, also for the original instructions high positive expectancies were found 
(Langens & Schuler, 2007b). Finally, our hidden administration differed from similar 
approaches in medical research. In contrast to receiving a medication unaware of the 
administration, we provided a non-therapeutic rationale in order to ensure that both 
experimental conditions did not differ in their credibility (e.g. Langens & Schüler, 2007).  
With regard to the trust game, we eliminated the possibility to capture changes across 
different rounds, because the subjective experience of trust was only measured before and 
after the trust game. By this procedure we tried to prevent again priming the participants to 
the topic of trust, thereby introducing a bias to our assessment (Légal, Chappé, Coiffard, & 
Villard-Forest, 2012). Second, we included, a dependent and an independent variable of trust 
in the same paradigm, which might have lead to circular nature of the experiment, since we 
induced and measured trust by the trust game. Since this problem is already embedded in the 
trust game, we aimed to counteract this by including the subjective trust rating as a second 
indicator variable. Finally, our trust induction might have been confounded by anger and 
anxiety, since our effect was attenuated when including anger and anxiety in the model. 
Understanding the particular nature of this association (anxiety, anger and in particular of 
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positive emotions and trust) and how these feelings interact might be particular important 
with regard to patient centered care. Economic psychology has addressed this question 
already and might provide some insights also for health care research ( e.g. Dunn & 
Schweitzer, 2005), 
6.5 Conclusion and implications 
Our meta-analysis highlights the need to differentiate between outcome dimensions in 
proposed trust models, since we found varying associations between trust and different type of 
outcomes. Also it needs to be investigated whether the positive impact of trust on subjective 
health, might in turn lead to improvements on objective outcomes (Wampold & Imel, 2015). 
We could not test for such an impact in our experiment as well as in the meta analysis – 
because of the supposed more complex nature of the phenomena including moderator 
variables like adherence to treatment, which was not addressable by our studies. Controlling 
and testing for the influence of demographic and cultural covariates might entangle the 
complex interaction. Also these complex interactions between trust and health outcome, 
including reverse causality, as well as the existence of moderators might be best addressable 
by prospective studies.  For instance in a longitudinal study repeated trust measurements 
might provide a more precise insight on the trust development of the patient. Based on our 
result that a systematic trust induction is possible, not only the use of questionnaires but also 
methods to manipulate the trust level could give an answer on to causal questions on the trust 
- health outcome association.  
A conceptual clarification of key variables would promote the debate on trust and 
allows the deduction of empirically testable hypotheses. Also the influence of distal factors 
(political, social and cultural variables) on the association between trust and outcome needs to 
be tested. For example Blendon and colleagues assume that the structures in which health care 
providers can take influence on health policy vary among countries, influences the trust of the 
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patient. As mentioned before Blendon and colleagues found a smaller correlation between 
trust in the provider and health outcome in North America than in Europe. The authors 
suggests, that Europe might have a more formal structures, in which physician leaders have 
the opportunity to negotiate with the government over issues, as payment and professional 
autonomy, which in turn might have an influence on the trust perception of the patient 
(Blendon et al., 2014). This direct assumed association between the health care system and 
trust of the patient, however, needs to be tested empirically. 
It appears tempting to implement suggested predictors of trust as a cost-effective way 
to enhance trust in clinical care (Keating, Gandhi, Orav, Bates, & Ayanian, 2004; Ommen, 
Thuem, Pfaff, & Janssen, 2011). Training programs have been developed to enhance trust 
relations in clinical practice (e.g. communication skill training). So far these interventions 
have failed to show any effects on trust (McKinstry, Ashcroft, Car, Freeman, & Sheikh, 2006; 
Rolfe, Cash-Gibson, Car, Sheikh, & McKinstry, 2014). Bearing in mind that trust has been 
divided into confidence in professional competence and intentional trust, which implies that 
the patients feels that she/he is treated in her/his best interest (Michael Calnan & Rowe, 
2008), it can be argued that with reference to the first part of trust (competence) skill trainings 
might improve health outcome, in terms of facilitating a competent and efficient treatment. 
Regarding intentional trust, these specific training programs might be of little benefit. On the 
contrary, training particular skills on how to act trustworthy might harm the authentic patient-
provider relationship.  
Moreover, in our paradigm the trust induction was found to be a complex 
phenomenon. For instance, the effect of the trust manipulation was influenced by anger and 
anxiety of the participants. Capra (2004) highlights that in the trust game identical logical 
structures (the same payoff) can be perceived differently depending on the participant’s 
mood. Moreover, Eberl (2004) describe with regard to the trust game that participants check 
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for a sufficient emotional attachment to the experimenter. This is accordance with the idea of 
intentional or so called identification based trust, which is based on personal values and 
feelings of both parties (Roy J Lewicki & Wiethoff, 2006). In this context temporary 
emotions might form the basis for a longer trust development. Putting our results in the 
context of emotional attachment we suggest, that the trust game and the development of trust 
needs to be investigated in a more realistic social context, where the role of emotions and 
relationship towards a second person can be studied in a more systematic way. 
Trust is essential when transforming meaning in treatment (Benedetti, 2013). In 
coherence with results on the context effects of trust, we found that meaning has an impact on 
treatment outcome. We were able to create a manipulation of the therapeutic meaning while 
keeping characteristics of the treatment constant. This open/hidden design might be promising 
for psychotherapy research and needs to be elaborated in order to test it in a clinical context. With 
regard to ethical considerations and based on our results common factor of meaning 
transformation should be transparent for the psychotherapist and the patient (J. Gaab, Blease, 
Locher, & Gerger, 2015). Frank (1986) stated that psychotherapy seeks to help patients to 
transform the meanings of their problems and symptoms by offering a narrative that explains 
the connection between symptoms and causes and thereby providing a way to overcome these 
obstacles. We found such an effect only for negative but not for positive affect. Based on 
these results, one might assume that meaning transformation could have a different impact on 
reducing negative symptoms than on enhancing positive health outcomes. To test this 
hypothesis I suggest studying the impact of meaning transformation with regard to different 
(negative and positive) health variables, as for instance clinical (e.g. number of symptoms, 
health behavior as adherence) or cognitive outcomes (e.g. reaction time, attention span). 
To conclude, by the systematic manipulation and empirical testing of two context 
factors, namely trust in the provider and meaning transformation in treatment, it might not 
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only be possible to control for their effects in clinical studies, but also to systematically use 
them in order to improve the treatment of the patient. 
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Abstract
Objective
To examine whether patients’ trust in the health care professional is associated with health
outcomes.
Study selection
We searched 4 major electronic databases for studies that reported quantitative data on the
association between trust in the health care professional and health outcome. We screened
the full-texts of 400 publications and included 47 studies in our meta-analysis.
Data extraction and data synthesis
We conducted random effects meta-analyses and meta-regressions and calculated correla-
tion coefficients with corresponding 95% confidence intervals. Two interdependent
researchers assessed the quality of the included studies using the Strengthening the
Reporting of Observational Studies in Epidemiology guidelines.
Results
Overall, we found a small to moderate correlation between trust and health outcomes (r =
0.24, 95% CI: 0.19–0.29). Subgroup analyses revealed a moderate correlation between trust
and self-rated subjective health outcomes (r = 0.30, 0.24–0.35). Correlations between trust
and objective (r = -0.02, -0.08–0.03) as well as observer-rated outcomes (r = 0.10, -0.16–
0.36) were non-significant. Exploratory analyses showed a large correlation between trust
and patient satisfaction and somewhat smaller correlations with health behaviours, quality of
life and symptom severity. Heterogeneity was small to moderate across the analyses.
Conclusions
From a clinical perspective, patients reported more beneficial health behaviours, less symp-
toms and higher quality of life and to be more satisfied with treatment when they had higher
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interplay between trust and health outcomes.
Introduction
Patients’ trust in their health care professional is central to clinical practice [1, 2]. The General
Medical Council states that "(p)atients must be able to trust doctors with their lives and health"
and that maintaining trust is one core guidance for physicians [3]. Similar obligations are part
of codes of conduct for other health care professionals such as nurses [4] or psychotherapists
[5]. Patients have to trust their health care professionals to work in their best interest and out-
come [6]. In this regard, trust in the health care professional has been suggested to be the foun-
dation for effective treatments [7, 8] and fundamental for patient-centered care [9].
Besides such a deontological obligation for trust theoretical models describe mechanisms
on how trust may influence health outcomes [7, 10–12]. Some of those conceptualize trust in
the health care provider in relation to the patient-clinician relationship, which has previously
been shown to be significantly associated with health outcomes across 13 RCTs [13]. There-
fore, the question arises whether trust in the health care professional is as well associated with
patients’ health.
Empirical evidence regarding this question comes from a growing number of studies that
report correlations between trust measures and patients’ health outcome. In the different stud-
ies the health outcomes encompass different dimensions, such as objectively measured indica-
tors (e.g. CD4 cell counts) [14], clinical observations (e.g. clinical diagnoses) [15], and patients’
subjective self-ratings (e.g. patient satisfaction) [16]. The association between trust and health
outcome has been found to differ across individual studies. For instance,in a sample of patients
with diabetes, trust in the health care professional was found to be positively related to objec-
tive and subjective health outcomes (glycemic control, health-related quality of life, and patient
satisfaction) [12]. In contrast, there was no significant association between trust in the health
care professional and subjective outcomes (blood pressure control) in patients with hyperten-
sion [17]. In the absence of a systematic and comprehensive summary of the available evidence
the variation in the observed health outcomes and in disorders complicates conclusions
regarding the association between trust and health.
The empirical confirmation of the assumed association between trust and health outcome
would strengthen the—so far—ethically derived claims for trustful and patient-centered rela-
tionships in clinical settings [2, 18, 19]. Therefore, a comprehensive and differentiated sum-
mary of the available evidence is needed. We conducted a systematic review with meta-
analysis of observational studies in order to (1) estimate the overall association between trust
and health outcome and to (2) investigate whether the strength of such an association depends
on the type of health outcome. We controlled for a potential impact of study methodology and
design on the association between trust and health outcome.
Methods
Data sources and searches
We conducted a systematic literature search in bibliographic databases (CINAHL, Embase,
MEDLINE and PsycINFO; see S1 File, which summarizes the applied search strategies). All
records were transferred to EndNote (EndNote X7 Thomson Reuters, USA), where duplicates
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were eliminated and all titles and abstracts were screened for inclusion and exclusion criteria.
Records were excluded if they clearly did not meet our inclusion criteria (J.B.). Two research-
ers then independently reviewed the full text of the records that were considered potentially
relevant during title and abstract screening (J.B. and C.W.). Ambiguities were resolved by con-
sensus or by consulting a third researcher (H.G.). If only the title, the author or journal names
were provided by the electronic database search, we contacted the authors or searched the
journal archives manually in order to check for eligibility. Records were excluded if we were
unable to obtain the full-text (Fig 1).
Study selection
We included studies that (1) reported quantitative data on the association between trust in the
health care professional and health outcomes (exclusion of case vignettes, interviews, reviews,
etc.), (2) took place in a health care setting, were written in English or German, (4) were pub-
lished journal articles and (5) measured interpersonal trust (e.g. trust in the nurse, physician,
GP, psychiatrist) with a valid, reliable and established trust questionnaire (i.e. included a refer-
ence to a published article which used the respective trust questionnaire; self-created, adapted
and single-item questionnaires were excluded).
To qualify as health outcome the dependent variable needed to relate to at least one of the fol-
lowing health dimensions: (a) aetiology of the health problem (e.g. physiological measures, such
as CD4 cell count, HbA1c), (b) symptoms (e.g. depression, worries, mood), (c) treatment-related
Fig 1. Study selection procedure.
doi:10.1371/journal.pone.0170988.g001
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indicators (e.g. adherence, health promoting lifestyle, satisfaction with treatment), or (d) conse-
quences of being in treatment (e.g. patient satisfaction, health-related quality of life, functional
level, overall health, cognitive and emotional change). In cases of uncertainty (e.g. online search
behaviour) we required that the authors provide at least one reference to an article that showed
an association between a particular outcome and one of the previously outlined health dimen-
sions. Moreover, the outcome needed to have a clear direction in order to distinguish between
positive versus negative health outcome (e.g. increase in CD4 cell count, and decrease on a scale
measuring depression symptom severity indicate improvement). We excluded outcomes when-
ever it remained unclear whether an increase or decrease on the respective measure was a bene-
ficial outcome for the patient (see S1 Table for a list of the included health outcomes).
Data extraction and quality assessment
Two researchers (J.B. and S.H.) independently extracted correlations between trust in the
health care provider and health outcomes whenever reported. If correlations were not re-
ported, we used the available binary data (i.e. numbers / proportions of events) or the provided
odds ratios in order to estimate the association between trust in the health care provider and
health outcome. Binary data and odds ratios were transformed into log odds ratios, then into
Fisher’s Z and finally into correlations. If data from two studies were reported in one publica-
tion, we extracted data from each study independently.
We extracted the diagnoses in the patient sample, the country in which the study was con-
ducted, the duration of treatment and characteristics of the trust scale. For quality assessment
of the included studies we used the STROBE (Strengthening the Reporting of Observational
Studies in Epidemiology) checklist with a maximum of 22 points [20].
Health outcomes were clustered into objective (e.g. blood pressure, HbA1C, BMI), observer-
rated (e.g. diagnosis by a professional) as well as self-rated subjective outcomes. The latter were
divided into self-reported health behaviours (e.g. medication adherence, screening behaviour,
health promoting lifestyle, online search behaviour) and health-related subjective experiences
(e.g. patient satisfaction, health-related quality of life, pain-related anger, depression, worries).
Following a thorough training, data extraction and coding was conducted independently by
two researchers (J.B. and S.H.) using a standardized form (Microsoft Office Excel 2007). Dis-
crepancies between the two coders were resolved in face-to-face discussions or by consulting a
third researcher (H.G.) when no consensus could be found.
Data synthesis and analysis
We calculated correlation coefficients in order to estimate the association between trust in the
health care professional and health outcome with the corresponding 95% confidence interval
(CI). With regard to the magnitude of effect sizes, we interpreted correlation coefficients in the
order of 0.10 as “small”, those of 0.30 as “moderate,” and those of 0.50 or higher as “large”
[21]. Whenever data was reported for subgroups of study participants in one publication, we
calculated the weighted mean correlation [22]. If the N was missing in the table of analysis, we
used the N of the descriptive statistics, ignoring the possibility that not all study participants
may have contributed data for the correlational analyses. If only subscales of a composite
health outcome measure were reported, we coded the available subscale data according to our
classification of health outcomes. However, we preferred total scores over subscale data, if
available. When more than one health outcome was reported in a publication, we combined
the data from different outcome measures so that each study contributed only one estimate
per analysis to avoid dependencies in the data.
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In a primary analysis, we calculated an overall estimate across all health outcomes. Then,
we calculated separate estimates for objective, observer-rated and self-rated subjective out-
comes. We further divided subjective self-rated outcomes into health behaviours and subjec-
tive experiences and estimated the impact of potential moderators (i.e. study quality, duration
of the treatment, the country in which the study was conducted, and the applied trust ques-
tionnaire). In an exploratory sub-analysis we divided subjective experiences into patient satis-
faction, quality of life and symptom-related outcomes and conducted individual subgroup-
analyses. For the subgroup and moderator analyses including categorical predictors we con-
ducted stratified meta-analyses; in case of continuous outcomes we conducted meta-
regressions.
We explored the presence of small study bias and publication bias by assessing funnel plot
asymmetry (i.e. whether negative or non-significant findings are missing) with a regression
test [23]. We inspected the Egger’s regression coefficient rather than the Begg’s correlation,
since the power for this test is higher [24]. We calculated a fail-safe N, which determines the
number of unretrieved studies with a null-finding that would bring the pooled estimate to zero
[25]. Finally, we applied the trim and fill method, which adjusts the association between trust
in the health care professional and health outcome for missing studies using the random effects
model and adjusting for studies missing at the left side of the mean [26]. We used Comprehen-
sive Meta-Analysis, version 2.0 (available at www.meta-analysis.com) for all meta-analyses and
subgroup analyses, and STAT 13.1 for the meta-regressions. We used a two-sided P-value to
test for statistical significance.
We applied random effects rather than a fixed effect model, since the included studies were
expected to be heterogonous in several respects. To evaluate heterogeneity between studies, we
examined τ2, which is an estimate of the variance among true effect sizes. τ (square root of τ2)
represents the standard deviation of the distribution underlying the included trials assumed to
be a random sample. Higher τ2-values indicate greater variability between studies than would
be expected by chance. Based on the definition of small, moderate, and large effect size esti-
mates according to Cohen in 1988 [21] we interpreted τ2 as follows: τ2 = (0.2/2)2 = 0.01 was
considered to represent low heterogeneity, τ2 = 0.06 [(0.5/2)2] moderate heterogeneity, and τ2
= 0.16 [(0.8/2)2] high heterogeneity between studies. As a measure of heterogeneity, τ2 has
been shown to be independent of the number of studies and patients included in a meta-analy-
sis (i.e. no increase with large numbers of studies or large sample sizes) [27].
Results
Descriptives of included studies
We included 47 studies that were published in 45 reports (see S1 Table for descriptive informa-
tion and the references of the included studies) with 34 817 participants (median: 200 partici-
pants, range: 24 to 8392). The procedure of study selection, including reasons for exclusion
after full-text review, is shown in Fig 1. Studies were conducted in Asia (2), Europe (6), North
America (34), and Australia (2). Two studies did not specify the country, and one study was
conducted in more than one country. In 24 studies trust was measured by the Trust in Physi-
cian Scale [28], six studies used the Wake Forest Trust Scale [29], four studies the Trust Scale
of the Primary Care Assessment Survey [30], three studies applied the Trust Scale of the Illness
Concept Scale [31], two used the Consumer Assessment of Healthcare Providers and Systems
(CAHPS) Cultural Competence [32], and two used the Trust Scale of the Cologne Patient
Questionnaire [33]. Six trust questionnaires were only used in one study (see S1 Table for
details). 33 studies reported correlations between trust in the health care professional and
health outcome and 15 studies reported binary data or odds ratios. Most studies did not report
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the order of assessment of trust and outcome. Four studies specified that the trust measure-
ment preceded the outcome assessment. No study reported on a reverse order of data collec-
tion (i.e. outcome assessment preceded the trust assessment). If no information was given, we
assumed that trust and outcome were assessed at the same time-point. 15 studies reported
objective health outcomes; two studies reported observer-rated outcomes and 42 studies
reported subjective self-rated outcomes. Most studies included participants with chronic and
multiple health complaints (see S1 Table). Six studies defined the duration of treatment with a
median of 1.7 months (range: 10 days to 5 years). Two studies reported a mean of 2.6 and 2.7
visits in the study sample. Study quality ranged from 7.5 to 18.5 STROBE points (median: 15
mean: 13.5). Studies were published between 1981 and 2013 (median: 2009).
Association between trust and health outcome: Primary, secondary and
exploratory analyses
Across all outcomes, we found a small to moderate correlation between trust and health out-
come (r = 0.24, 95% CI: 0.19 to 0.29) based on all 47 studies (Table 1 and S2 File, which shows
all forest plots). Heterogeneity between studies was low to moderate.
Stratified analyses revealed small and non-significant correlations in case of objective out-
comes and observer-rated outcomes (r = -0.02, -0.08 to 0.03 and r = 0.10, -0.16 to 0.36 respec-
tively; see S2 File for the respective forest plots), as well as a moderate correlation with regard
to subjective self-rated outcomes (r = 0.30, 0.24 to 0.35). Heterogeneity was small to moderate.
In a subgroup analysis, we found a small correlation (r = 0.14, 0.10 to 0.19) between trust
and patients’ health behaviours and a moderate correlation between trust and health-related
subjective experiences (r = 0.37, 0.27 to 0.47; Table 1). Our final stratification of the health-
related subjective experiences showed a large association between trust and patient satisfaction
(r = 0.57, 0.49 to 0.64) and small associations between trust and health-related quality of life
(r = 0.18, 0.14 to 0.22) and symptom-related outcomes (r = 0.13, 0.04 to 0.22). Small to moder-
ate between-study heterogeneity remained unexplained in most explorative analyses (Table 1).
Publication bias
Despite a significant Egger’s regression test in the overall analysis as well as in the analysis
using only studies with a health behaviour as outcome (P< 0.001), the fail-safe N and the
Table 1. Associations between Trust in the Health Care Professional and Health Outcome stratified according to the Outcome Dimension.
Analysis N of studies (patients) r 95% CI p τ2 Publication bias
Egger test (p) Fail-safe N Trim & Fill test
Overall 47 (34 817) 0.24 0.19, 0.29 <0.001 0.03 <0.001 9 328 0.24
Objective 15 (7 867) -0.02 -0.08, 0.03 0.430 0.01 0.518 0 -0.02
Observer-rated 2 (706) 0.10 -0.16, 0.36 0.445 0.04 - - -
Subjective, self-rated 42 (30 943) 0.30 0.24, 0.35 <0.001 0.04 <0.001 10 532 0.30
Behaviour 21 (26 642) 0.14 0.10, 0.19 <0.001 0.01 0.010 1 857 0.14
Experience 29 (10 229) 0.37 0.27, 0.47 <0.001 0.09 0.226 23 39 0.37
Satisfaction 15 (5 141) 0.57 0.49, 0.64 <0.001 0.04 0.636 8 007 0.57
HRQoL 5 (1 816) 0.18 0.14, 0.22 <0.001 <0.01 0.134 93 0.17
Symptom-related 13 (4 285) 0.13 0.04, 0.22 0.004 0.02 0.333 263 0.13
Note. Study is used as the the unit of analysis. Ns of Subanalysis (objective, observer-rated and subjective, self-rated) do not add up to 34 817, since
several studies included more than one outcome. r = correlation; CI = confidence interval; τ2 = variability between studies;— = no estimate provided due to
small number of included studies; HRQoL = health-related quality of life.
doi:10.1371/journal.pone.0170988.t001
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trim-and-fill analyses indicate a small risk for publication bias (Table 1 and S3 File, which
shows the funnel plots).
Meta-regressions and subgroup analyses
Meta-regressions with study quality and treatment duration as predictors showed that the
association between trust and outcome depended on study quality, with smaller associations
in higher quality studies (Table 2 and S4 File, which shows the scatter plots of the meta-regres-
sions). Furthermore, based on six reports of treatment duration, we found the correlation
between trust and outcome to be independent of treatment duration (Table 2 and S4 File).
In both meta-regressions one outlier study was identified. Repeated analyses excluding the
respective outliers showed similar results as the initial analyses (see S4 File).
Stratified analyses showed some variation in associations between trust and outcome when
studies were conducted in different geographical regions but no variation when different trust
questionnaires were used (Table 3). Further analyses showed considerable differences when
correlational data vs. binary data were reported and finally a meta-analysis restricted to the
prospective studies showed a comparable correlation as the analysis including all studies (see
Table 3 and S2 File, which shows the respective forest plots).
Table 2. Meta-Regressions of the Association between Trust in the Health Care Professional and Health Outcome according to Study Quality,
Duration of Treatment.
Moderator N of studies B 95% CI p τ2
STROBE (study quality) 47 -0.033 -0.07, -0.003 0.074 0.06
Duration of treatment 6 -0.001 -0.01, 0.01 0.751 0.02
Note. N = number of studies included in the analysis; B = unstandardized regression coefficient from meta-regression; CI = confidence interval; τ2 =
variability between studies for the intercept of the model only; STROBE = Strengthening the Reporting of Observational Studies in Epidemiology (study
quality).
doi:10.1371/journal.pone.0170988.t002
Table 3. Associations between Trust in the Health Care Professional and Health Outcome stratified according to the Geographic Region, Trust
Questionnaire and Type of Data.
Subgroup Analysis N of studies (patients) r 95% CI p τ2
Countrya
Asia 2 (536) 0.13 0.10, 0.15 <0.001 <0.01
Australia 2 (665) 0.35 -0.31, 0.79 0.298 0.25
Europe 6 (848) 0.36 0.22, 0.48 <0.001 0.03
North America 34 (31 780) 0.22 0.16, 0.28 <0.001 0.04
Trust Questionnairea
Trust in Physician Scaleb 24 (17 650) 0.27 0.19, 0.35 <0.001 0.04
Other Trust Questionnaires 23 (17 167) 0.19 0.13, 0.25 <0.001 0.02
Type of Data
Correlational Data 33 (19492) 0.27 0.26, 0.28 <0.001 <0.01
Binary Data 15 (206867) 0.05 0.03, 0.08 <0.001 0.05
Prospective Data 4 (1584) 0.23 -0.02, 0.45 0.072 0.06
Note. Study is used as the the unit of analyses. r = correlation; CI = confidence interval.
a Studies do not add up to 47 due to missing information.
b Anderson LA, Dedrick RF. Development of the Trust in Physician Scale: a measure to assess interpersonal trust in patient-physician relationships.
Psychol Rep 1990;67:1091–100.
doi:10.1371/journal.pone.0170988.t003
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Discussion
We observed a significant association between trust in the health care professional and health
outcome. However, results differed with regard to the outcome dimension, with small and
non-significant correlations for objective and observer-rated outcomes and a moderate associ-
ation with self-rated subjective outcomes. The association between trust and outcome was
smaller in high quality studies. Interestingly, the observed association between trust and health
appeared to be smaller when binary data were reported and larger, when correlations were
reported, and smaller in North America and Asia compared to Europe and Australia.
To the best of our knowledge, this is the first meta-analysis that provides an empirical esti-
mate of the association between trust in the health care professional and health outcome. Our
analyses included 34 817 participants from 47 studies in different clinical settings—i.e. disor-
ders and treatment duration varied across as well as within studies and studies were conducted
in diverse geographic regions with possibly diverse health care systems.
In order to reduce pragmatic heterogeneity, we included only studies that used a validated
trust questionnaire, and we clustered health outcomes into different health outcome dimen-
sions. Furthermore, we checked whether the type of questionnaire moderated study results
and confirmed the robustness of the overall finding in a subgroup of 24 studies that all used
the same trust questionnaire.
Our meta-analysis has several limitations. First, there are indications that our overall results
may be overestimated. We found smaller associations in higher quality studies as well as in
larger studies and the significant Egger’s test indicates a lack of small-scaled studies with non-
significant correlations (Table 2 and S3 File for funnel plots). However, the large fail-safe N in
our analysis indicated a very low risk for a non-significant overall association between trust in
the health care professional and health outcome. Second, we were not able to satisfactorily esti-
mate the impact of potential moderators. Here, a reasonable classification of patient character-
istics was not possible due to the fact that most samples were mixed with respect to potentially
relevant characteristics (e.g. ethnicity or disorder). Also, only six studies reported details on
treatment duration. This resulted in a low power of our meta-regression. Statistical heteroge-
neity, however, was small to moderate in most analyses. This indicates only a small risk for the
presence of strong moderators. Finally and most importantly, our analyses do not allow causal
interpretations of the observed association between trust in the health care professional and
health outcome, since the vast majority of included studies were cross-sectional. However, a
subgroup-analysis including only the four prospective studies that assessed trust before the
outcome assessment, showed the same moderately sized association between trust and health
outcomes as the overall analysis including prospective and cross-sectional studies.
Patients’ trust in the health care professional may best be conceptualized as a contextual fac-
tor of treatment effects [10, 11, 34]. Indeed previous work mentions trust in relation to the
patient-clinician relationship, which is also embraced by the umbrella-term of contextual fac-
tors. Systematic reviews and meta-analyses of RCTs have found small to moderate associations
between such factors on health outcomes [13, 34]. Thus, given the risk that the overall associa-
tion between trust and outcome was overestimated in our meta-analysis, a slightly reduced
association in our study could be considered as complementing previous findings.
The differential finding for the type of outcome dimension—i.e. larger associations for the
self-rated subjective outcomes and a small or even non-significant association for objective
outcomes—has already been described by Beecher in 1955 and has been confirmed for diverse
contextual factors ever since [35–38].
A conceptual proximity between trust and subjective outcomes could explain the observed
large associations [6, 39]. Indeed, data from a large-scale survey empirically confirms a
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meaningful association between trust in the health care professional and subjective health [8].
However, since meta-analyses described an enhanced risk of bias with regard to self-rated sub-
jective outcomes, possibly due to inadequate allocation concealment and inappropriate blind-
ing [40, 41], the particularly large associations in our analyses may result—at least partly—
from an upward bias.
The non-significant association between trust and objective health outcomes in our meta-
analyses may be seen as confirming the previous findings and thus, reflect a de facto absence of
such an association. However, we observed a significant correlation between trust and self-
rated subjective outcomes, which in turn have been associated with objective outcomes [42–
44]. Therefore, it could be argued that a possible association between trust and objective out-
comes depends on trust-sensitive subjective variables, such as adherence to medication or
patient satisfaction with treatment [45, 46]. We could not test the assumption of such a causal
chain, however, since the included studies did not stratify their results with regard to possible
trust-sensitive subjective variables. Considering that the establishment of interpersonal trust
has been described as evolving continuously rather than being a rigid state [47], the cross-sec-
tional study design of most included studies might have hindered the detection of a possible
time-delayed impact of trust on objective outcomes.
We found a larger association in studies that reported correlations and a lower association
in studies that reported binary data. This pattern was not due to a predominant use of objective
outcomes in the studies with binary data and subjective outcomes in the studies with correla-
tional data: Among the studies that reported correlations 33.33% reported objective data, and
among the studies that reported binary data 26.67% reported objective data. With regard to
the differences in the observed trust-outcome associations in Europe, North America, Austra-
lia, and Asia, which are in part also reflected in a recent survey on trust in physicians [48], it is
tempting to assume differences in health care systems [49] or in social and cultural factors [50]
to account for this finding. However, the available dataset of our meta-analysis did not allow
for the testing of these assumptions.
The summarized data indicate that patients report more beneficial health behaviours,
higher satisfaction and health-related quality of life, but also better symptom-oriented subjec-
tive outcomes when they had higher trust in their health care professional. These findings sub-
stantiate the asserted fundamental role of patients’ trust in the context of patient-centered care
[9, 18]. It appears tempting to implement the suggested predictors of trust [51, 52] in clinical
care as a feasible and possibly cost-effective way to enhance trust and, thus, health outcomes.
However, it remains debatable whether such action suffices [18]. First, it must be taken into
account that trust and health outcomes may mutually affect each other [6, 43]. Also, trust has
been argued to be highly sensitive to more distal, i.e. political, social, and cultural processes
[50], which could possibly be reflected in the geographical differences in our analyses. Thus, a
sustainable investment should encompass the micro (e.g. patient-provider relationship, quality
of health care provision) as well as the macro level (e.g. organisation, financing, and structure
of the health care service) [53].
Previous research has proposed different models on how trust could influence health out-
comes [45]. For example, Lee and Lin proposed that patients’ trust influences the health out-
comes via patient disclosure, the placebo effect, compliance, and the physician’s caring
behaviour [54]. Although this model particularly focuses on the association between patients’
trust and health outcomes, it lacks conceptual clarity, for instance with respect to the definition
of health outcomes and the influence of more distal factors as well as possible mediators and
moderators. Our study highlights the need to differentiate between outcome dimensions. For
instance, in accordance with the model proposed by Wampold and Imel, trust in the health
care professional might have a positive impact on subjective health (e.g. beneficial health
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behaviors), which might then, in turn, lead to improvements on objective outcomes [11].
Accordingly, a conceptual clarification of key variables would not only advance the debate on
trust, but also allow the deduction of empirically testable hypotheses. The complex interactions
between trust and health outcome, including potentially time-delayed effects, reverse causality,
as well as the existence of moderators and mediators should further be investigated in prospec-
tive studies. Finally, the influence of distal factors (organizational, political, social as well as cul-
tural variables) on the association between trust and outcome needs to be tested and
considered in an all-encompassing model.
Conclusion
Across diverse clinical settings, patients reported to be more satisfied with treatment, to show
more beneficial health behaviours, less symptoms and higher quality of life when they had
higher trust in their health care professional. But there was no association between trust and
observer-rated or trust and objective health outcomes. Although further studies are required
to test the direction of the association between trust and health outcome, trust in the health
care professional may not only be a deontological constituent of clinical care [55], but it might
also be consequential for patients’ treatment satisfaction, health behaviours, symptom severity
and quality of life.
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Abstract 
Trust is considered a necessary prerequisite of consequential interpersonal encounters, 
such as societal, political, economical and therapeutic exchange relationships. With regard to 
the wealth of empirical evidence on trust, it needs to be noted that while there is a surplus of 
studies investigating trust as a dependent, covarying or predicting variable, the experimental 
manipulation of trust has received considerable less attention. Here, we examined and adapted 
the trust game, an established paradigm in economic psychology, and assessed the effects of 
random allocation to either a trustful or a non-trustful interaction on subjective as well as 
behavioral trust measures. The results show that trust can be experimentally manipulated.  
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Introduction  
Interpersonal trust is the fundament for societal [1], organizational [2], family [3], 
political [4, 5] and economical exchange relationships [6, 7]. Furthermore interpersonal trust 
is also considered fundamental for the clinical encounter, although its specific role in the 
treatment process still needs to be elucidated [8, 9]. In the clinical setting, a variety of 
observational studies have investigated the relationship between trust and health outcome 
[10]. While these studies provide correlational data, they cannot give evidence for causality. 
Also, some trials evaluated so-called trust trainings, which set out to improve patients' trust in 
their doctors, although with sobering effects [11]. On the basis of these findings, it has been 
noted “that trust is important for its potential therapeutic effects although evidence to support 
such claims is still in short to supply mainly because of the lack of intervention studies or 
quasi-experimental studies examining the effect of trust on health outcomes…” [8]. This lack 
might be due to the fact that trust is a multifactorial and complex concept that differs among 
situations and changes over time [12].  
In the domain of economic psychology, the trust game by Berg, Dickhaut and McCabe 
(1995) is a well-elaborated and replicated method to measure trust in an experimental setting, 
including the sequential momentary exchange of two parties, with no predefined contract or 
agreement [13]. Here, the vast majority of trust game studies focus on trust as a dependent 
variable [14-16], although there are noteworthy exceptions, with experimental induction of 
distrust in two studies so far [17, 18]. However, these (dis-)trust manipulations were 
uncontrolled for a trust condition. 
Furthermore, whereas the trust game has predominantly been seen in the context of 
expected maximization of the monetary payoffs, several authors have postulated that the 
participants’ behavior is better understood in the framing of a social interaction [19]. 
Noteworthy and in consequence, Castelfranchi & Falcone (2000) highlighted the limits of the 
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strategic tradition of trust for the transfer to real life situations, assuming that the trustor forms 
a theory of mind of the trustee, including personality, morality, and shared values, not 
realizable by the use of a computerized partner [20]. Since trust-relevant situations are 
complex and interactive, it is both difficult to transfer results from an anonymous trust game 
as much as to exclude or control for confounding variables in a natural environment, e.g. in a 
clinical setting [21, 22]. This is especially true with regard to anonymity, a factor extensively 
debated in trust game research. It has been hypothesized that when anonymity is disregarded 
in the trust game other factors might play a substantial role as the protection of the own 
reputation or the fear of retribution [13]. 
Considering on the one hand the assumed importance of trust for various domains and 
on the other hand the lack of an established paradigm to experimentally manipulated trust, the 
primary objective of the current study was to investigate whether the trust game might 
provide a tool to induce trust by using two fixed conditions (a trust and a non trust condition). 
We tested this by assigning the role of the trustee to a non-anonymous experimenter, thereby 
providing a more naturalistic setting, in order to compare participants’ subjective experience 
with their behavioral response, i.e. transferred money.  
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Methods 
Participants and procedure 
In total, 106 male participants were enrolled in the current study (mean age = 24.5 
years, SD = 4.7 years). Participants were recruited by advertisement at the University of 
Basel, via two online recruitment system of the University of Basel (BAPS-Sona, 
http://baps.sona-systems.com and markt.unibas.ch). Potential participants were previously 
checked for inclusion by the use of an Internet survey. Inclusion criteria were male gender, 
age between 18 to 40 years and sufficient German language skills. Exclusion criteria were any 
acute or chronic disease by self-report. 
Trust game 
The study was conducted at the Department of Psychology of the University of Basel. 
The experiment consisted of one session (2 hours). The participants played a trust game, 
adapted from Berg, Dickhaut and McCabe (1995), but were told they were going to play a 
cognitive task in its context they could win some additional money [23]. Some changes were 
made in order to manipulate the participant’s level of trust. Starting with an endowment of 1 
start unit in each round, the participant could decide to send a particular portion of their 
endowment to the investigator. In total, five rounds were played. In round 1 and 2, the 
participant could send 25%, 50% or 75% of their endowment; while in round 3, 4 and 5 also 
0% or 100% could be send. After the participant sent the money, the amount was tripled. The 
investigator (in the role of the trustee) in return passed a predefined amount of money back, 
depending on the condition (see below).  
Participants were randomly assigned (by lot) to the non-trust or trust condition 
immediately before the trust game started. In the non-trust condition the investigator returned 
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50%, 0%, 25%, 0% and 0% of the amount sent (round 1 to 5, respectively). The sent amount 
was tripled. With regard to the trust condition, based on the fairness heuristic that trust should 
be facilitated when the decision yields maximum rewards for both parties, the experimenter 
always returned 50% of the tripled amount in order to create a fair exchange [19]. The amount 
passed by the sender was defined to capture the behavioral response of trust [23]. The gain 
was disbursed at the end of the experiment and no feedback was given from the experimenter. 
Before and after the trust game we employed the State-Trait-Anxiety-Inventory 
(STAI) to measure anxiety. The STAI is a standardized self-report questionnaire, measuring 
anxiety both as state (X1) as well as a trait (X2). Both scales contain 20 items and a four-point 
ranking scale, ranging from 1 = almost never to 4 = almost always. Cronbach’s alpha for both 
scales is found to be α = .90 [24]. Negative items were recoded. Higher items indicate a 
higher level of anxiety. Also, we used the State-Trait-Anger-Expression-Inventory (STAXI) 
before and after the trust game, which assesses five subscales of anger: state anger (10 items), 
trait anger (10 items), and anger expression (24 items). Items are rated on a four-point ranking 
scale from 1 = not at all to 4 = very much. Cronbach’s alpha coefficient ranges from .75 to .82 
for the different scales [25]. As a subjective measure of trust, participants were asked to 
indicate how trustful they perceived the investigator on a 10 cm adapted visual analogue scale 
(VAS) before (baseline) and after the trust game [26]. The intensity scale ranged from 0 (no 
trust) to 100 (high trust). Higher scores indicated higher trust. All instructions given to 
participants as well as the experiment’s technical procedure followed a standardized 
experimental protocol. The study was approved by the ‘Ethikkommission Nordwest- und 
Zentralschweiz (EKNZ)’ and were registered by the ‘Clinical Trial Registration’ (EKNZ 
2014-396, URL:https://clinicaltrials.gov/ct2/results?term=EKNZ+2014-396&Search=Search). 
For compensation, participants received either study credits or CHF 50.  
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Statistical analysis 
To test whether the trust condition was associated with differences in the trust rating 
of the experimenter, we conducted an analysis of covariance (ANCOVA), including trust-
condition as the fixed factor and the baseline trust measurement as the covariate. In a second 
step, we also held STAI- and STAXI pre-post difference constant in order to control for anger 
or anxiety. With regard to the behavioral level, we investigated whether the trust condition 
was also associated with differences in the amount send by the participant. Therefore we 
calculated separate chi-square tests as an explanatory analysis. Also separated t-tests were 
conducted in order to test for differences in mean percentage of the passed amount. To verify 
the normality, linearity and homoscedasticity assumption of the residuals, we inspected 
scatter-, box- and QQ-plots and checked for outliers (leverage, Cook’s distance and 
Mahalanobis distance). Since distribution was skewed we excluded one participant (with 
regard to his values with regard to leverage, Cook’s distance and Mahalanobis distance). For 
all tests the significance level was set to .05. Statistical analyses were performed using IBM 
SPSS Statistics Version 22.   
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Results 
Subjective trust rating: Visual analogue scale on trust (VAS) 
Overall, 106 participants underwent the experimental manipulation of trust (trust 
condition N = 53 distrust condition N = 53). Participants in the two conditions did not differ 
regarding mean age in years, baseline scores in the psychometric assessment of anxiety and 
anger as well as in baseline trust-rating (see Table 1). The experimental variation of trust led 
to significant time by group interaction effect for anger (F(1, 104) = 7.24, p = .008, ηp2 = .065) 
but not for anxiety (F(1 102) = .078, . ηp2 = .030). Controlling for the baseline subjective trust-
rating as covariate, the post ratings of subjective trust rating showed a main effect of the trust 
condition after the trust game (F(1, 102) = 4.47, p = .037, ηp2 = .042), with participants in the 
trust condition rating the experimenter as significantly more trustworthy. For exploratory 
analysis, a mixed model ANOVA showed a significant interaction (F(1, 104) = 5.08, p = .026, 
ηp2 = .047), which reflects a decrease in the non-trust condition after the trust game, whereas 
for the trust condition no difference in the subjective trust rating after the trust game was 
found (Fig 1). Controlling for pre-post differences of anxiety and anger, the previously 
observed significant effects were attenuated, yet still observable with a alpha error below 10% 
(F(1, 100) = 3.78, p = .055, ηp2 = .036) anger (F(1, 102) = 2.88, p = .093, ηp2 = .027 (see Table 
2).  
Fig 1. Subjective trust ratings before and after the trust game.  
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Table 1. Mean and standard deviation of the variables age, STAI, STAXI, trust-rating. 
Note. STAI = State-Trait-Anxiety-Inventory, STAXI = State-Trait-Anger-Expression-
Inventory, VAS = visual analogue scale, SD = standard deviation.  
 Non-trust Trust  
Dependent variable Mean SD Mean SD P-Value 
Age 24.51 5.15 24.53 4.15 0.938 
STAI      
Pre 33.21 7.36 33.23 6.71 0.987 
Post 33.63 8.23 32.30 6.63 0.363 
STAXI      
Pre 11.30 3.18 10.94 1.89 0.482 
Post 12.04 3.16 10.60 93 0.002 
Trust VAS (trust rating)      
Pre 88.00 10.57 86.49 14.61 0.544 
Post 83.42 16.98 86.28 14.23 0.348 
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Table 2. Effects of the trust manipulation for the trust rating and behavioral response 
with and without controlling for a covariate (anxiety and anger). 
aInteraction term: Time point (before vs after the trust game) x trust condition (non-trust vs 
trust group) with the trust rating as the dependent variable. 
bInvestement for the third round in the trust game. 
cFor this analysis an independent t-test (non-trust vs trust condition) was used.  
Dependent variable Df F/t P-value 
Trust ratinga 1 5.08 0.026 
Investmentbc 104 -2.62 0.027 
ANCOVA: anxiety as covariate    
Trust ratinga 1 3.76 0.055 
Investmentb 1 2.04 0.156 
ANCOVA: anger as covariate    
Trust ratinga 1 2.89 0.093 
Investmentb 1 .54 0.466 
11   
Behavioral response to the trust manipulation: Investment in trust 
game 
To operationalize behavioral consequences of the experimental trust manipulation, we 
assessed the investment of participants. In accordance with Haselhuhn (2010) [17], we 
dichotomized the investment into whether the participants sent money or not and conducted 
separate chi square tests. In both conditions participants invested on average more than 50% 
in each round. At round three, i.e. after trustors' behavior was experimentally manipulated and 
participants responded to the manipulation, a significant difference between non-trust and 
trust condition was detectable (χ2(1, N = 105) = 5.13, p = .020). Also, the mean percentage of 
the money passed by participant after trustors' behavior changed between groups was 
significantly higher in the trust condition (Fig 2) for round three (t(77.12) = -2.62, p = .027, d 
= .439). For round four and five no difference could be detected between non-trust and trust 
(round four: χ2(1, N = 105) = 0.29, p >.250, round five: χ2(1, N = 105) = 0.10, p >.250 and 
mean percentage: round four t(104) = .57, p > .250) round five t(104) = -.28, p > .250). When 
controlling for anger and anxiety the found difference between trust conditions in round three 
were no longer significant (anger: (F(1, 102) = 0.54, p = .466); anxiety: (F(1, 100) = 2.04, p = 
.156) (see Table 2).  
Correlation analysis revealed a significant correlation between subjective trust rating 
(post measure) and investment in round three (r = .22, p = .023) and a non-significant 
correlation for round four and five (round four: r = -.079, p = .422, round five: r = .144, p = 
.142). 
Fig 2. Investment in the non-trust and trust condition. Percentages beneath the round 
describe the response percentage sent by the trustee to the participant. Participants can react to 
the percentage of the trustee one round later.  
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Discussion 
The aim of the present study was to examine the effects of an experimental trust 
manipulation. We found a significant effect of the trust manipulation on the subjective as well 
as the behavioral trust level; whereas in the trust condition subjective rating of trust in the 
experimenter remained the same before and after the trust game, in the non-trust condition 
subjective trust ratings decreased significantly. Also, after the trust manipulation a significant 
difference between trust conditions could be detected on the behavioral level, with decreases 
in the percentage of participants choosing to pass any amount as well as in the mean 
percentage of passed money. However, these effects of the trust manipulation were transient, 
as for the two last rounds no differences were found in these behavioral parameters. Also, the 
trust manipulation led to significant increases in anger (but not anxiety) and changes in these 
affective parameters influenced the interventions effects on trust measures. 
In the following, our results will be discussed in the context of other findings and 
studies. First, with the employed paradigm, we were able to systematically manipulate the 
trust level of the participants. Previously, attempts have been made to vary the trust level in 
the trust game [15, 17, 19]. However, Haselhuhn included a distrust condition without 
controlling for a trust condition and Burks (2003) as well as Harth and Regner (2016) 
manipulated the trust condition only in an indirect way. Burks (2003) manipulated the trust 
level by letting participants play both roles of the trustor and the trustee in the trust game and 
found that playing both roles reduced the trust level in the participant [19]. Harth and Regner 
(2016) varied whether participants received feedback about the trustee's amount sent back 
[15]. Receiving feedback increased the anger level in the participant, which in turn let to a 
spiral of distrust. However, both studies did not systematically create a trust and a non-trust 
condition, but rather changed indicators that indirectly influence the trust level, as feedback or 
changing roles in the game. Our finding corroborates the induction of transient distrust 
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reported by Haselhuhn et al. (2010) [17]. Furthermore, we were to extend and strengthen 
these findings through the inclusion of a control group.  
Second, despite the observed significant drop in both subjective as well as in 
behavioral trust measures after the trust manipulation, our results also indicate that a certain 
amount of trust resists even in the presence of unexpected behavior of the trustor, which 
comes close to betrayal. This resistance was apparent for both - the subjective experience of 
trust as well as for the behavioral level: Participants investigated more than 50% in each 
round, regardless of their condition. Our findings are in line with results from Burnham and 
colleagues (2000) that participants still sent money in the case of increasing betrayal as even 
in the distrust condition, participants sent more than at least 19% of their endowment [27]. 
Third, the subjective experience of trust did not correspond with the behavioral 
response in rounds four and five, where no differences between trust and non-trust condition 
with regard to investment were found. Also, there was no correlation between trust rating and 
investment for round four and five. This seeming dissociation between subjective and 
behavioral trust operationalization confirms earlier and comparable findings. For example, 
Glaeser and colleagues (2000) reported that behavior in the trust game was predicted by past 
trusting behavior but not by the responses of the participant on a – albeit attitudinal – trust 
survey [28]. With regard to our results it is also possible that a similar decline of subjective 
trust has occurred, but was not detectable simply because we did not assess this parameter 
repeatedly, but measured only before and after the trust game. Also, the lack of a correlation 
might be due to a truly existing dissociation between trust perception and behavior in the 
fourth and fifth round. Based on our results it cannot be excluded that the subjective 
experience of trust might deviate from the replying investing behavior of the participant. 
Outside the frame of the trust game, trusting behavior has been linked to the expectations of 
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reciprocity rather than perceived trust [26]. Therefore, caution is warranted when equalizing 
the investment (trust behavior) as a measure of trust experience [13]. 
Finally, it has been argued that in a non-anonymous trust game participants might be 
more motivated by fear than by trust [29]. In our non-anonymous experiment, the effect of the 
trust manipulation was indeed influenced by anger and anxiety of the participants. These 
findings are in line with previous reports by Capra and colleagues who found that the 
perception of the trustors payoff (as high or low) depends on the mood state of the participant. 
Capra highlights that in a strategic interaction like the trust game, identical logical structures 
(the same payoff) can be perceived differently depending on the participant’s mood [30]. 
With our results we could support this finding, showing that participants did perceive the 
differences in payoff differently when the mood was held constant (differences between 
group attenuated). Moreover, Eberl and colleagues describe with regard to the trust game that 
participants try to test the trustors conscience, checking for a sufficient emotional bonding 
[31]. In this context temporary emotions (as anger and anxiety state) might form the basis for 
trust development, which has been ignored largely in trust game research. Putting our results 
in the context of emotional bonding we suggest, that the trust game and the development of 
trust needs to be investigated in a more realistic social context, where the role of emotions and 
relationship towards a second person can be studied in a more systematic way. 
To the best of our knowledge this is this first study using the trust game as an 
independent variable, i.e. systematically manipulating the trust level by changing trustors 
behavior. However, some limitations must be noted. First, as mentioned before, we only 
measured the subjective experience of trust before and after the trust game, eliminating the 
possibility to capture changes across different rounds. This was due to the fact that we try to 
prevent priming the participants to the topic of trust, thereby introducing a bias to our 
assessment [32]. Second, it might be reasoned that our trust manipulation is of circular nature, 
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including a dependent and an independent variable in the same paradigm. However, this 
problem is inherently embedded in the trust game and we tried to counteract this by including 
the subjective trust rating as a further variable. Moreover, we cannot fully exclude that our 
results were confounded by the induction of anger or anxiety. Therefore, we suggest that 
further research is needed in order to specify the role of emotions in the trust game. 
Conclusion 
Considering the ubiquitous importance of trust and the lack of experimental studies on 
this construct, we suggest that the present paradigm provides a possible approach to further 
elaborate the role of trust in different settings. For example, our paradigm could prove to be 
useful in the examination of trust in the clinical context. This implementation might also 
elucidate how trust is build and influences the participants’ response behavior in a real life 
situation, including emotions and the social context of the participant and the trustor. 
However, this is of course a matter of further studies.  
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ABSTRACT (word count 149) 
Psychotherapy has been shown to be effective, but efforts to prove specific effects by placebo-
controlled trials have been practically and conceptually hampered. We propose that adopting 
open/hidden designs from placebo research would offer a possible way to establish specificity in psy-
chotherapy. Therefore, we tested the effects of providing opposing treatment rationales in an online 
expressive writing intervention on affect in healthy subjects. Results indicate that it was possible to 
conduct the expressive writing intervention both covertly and openly, but that participants in the hid-
den administration condition did not fully benefit from the otherwise effective expressive writing in-
tervention in the long-run. Effect sizes between open and hidden administration groups were compa-
rable to pre-post effect sizes of the intervention. While this finding is important for the understanding 
of psychotherapy's effects per se, it also proves that alternative research approaches to establish speci-
ficity are feasible and informative in psychotherapy research. 
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INTRODUCTION (word count 739) 
There is consensus that psychotherapy is effective, yet identification of accountable factors or pro-
cesses is subject to controversy (Kazdin, 2007). Whereas in biomedical research the position that 
"preservation of sound judgment both in the laboratory and in the clinic requires the use of the "double 
blind" technique" (Beecher, 1955, p. 1606) is considered gold standard, this approach is not fully ap-
plicable in psychotherapy research. Although it needs to be noted that even in biomedical research not 
everything that glitters is gold (Fergusson, Glass, Waring, & Shapiro, 2004), the principle of indistin-
guishability between comparators is fundamentally hampered in psychotherapy trials both practically 
and conceptually (Kirsch, 2005). So far, two main approaches have been employed to handle this 
problem and to establish specificity in psychotherapy research, both with problematic consequences in 
their own right (Wampold & Imel, 2015, p. 213ff).  
First, since it is old lore that "to show that a specific form of psychotherapy (...) produces results not 
attributable to the non-specific placebo effect it is not sufficient to compare its results with (...) no 
treatment" (Rosenthal & Frank, 1956, p. 300), psychotherapy is to be compared to psychological pla-
cebo to establish specificity of the treatment (Chambless & Hollon, 1998). This seemingly adopts the 
gold standard of biomedical research and thus is considered good enough to be gentled as "Research-
supported psychological treatment" (American Psychological Association, Division 12). However, 
there is evidence that differences between psychotherapies and psychological placebo conditions1 are a 
function of the credibility of the placebo control (Kazdin & Wilcoxon, 1976; Locher et al., 2016) as 
well as the extent of structural equivalence between comparators (Baskin, Tierney, Minami, & 
Wampold, 2003) and that controlling for researchers' allegiance towards a particular intervention 
abolshes observed differences (e.g. Cuijpers et al., 2012). Second, specificity has been sought through 
direct comparisons of psychotherapies, which usually differ in their characteristic, but not in their in-
cidental treatment constituents (Grünbaum, 1981) and through dismantling or additive component 
studies, in which presumable characteristic treatment constituents are either omitted or added. Howev-
er, meta-analyses on respective trials do not substantiate the existence of statistically and/or clinically 
                                                       
1 Placebo conditions often run under various denominators, such as supportive therapy, nondirective therapy, common factor 
control, credible attention placebo, and modest contact, but should be and are considered as placebo as they are lacking 
treatment constituents deemed specific 
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significant differential effects per se (Ahn & Wampold, 2001; Bell, Marcus, & Goodlad, 2013; 
Fluckiger, Del Re, & Wampold, 2015; Marcus, O'Connell, Norris, & Sawaqdeh, 2014; Wampold et 
al., 1997), besides those are related to researchers' allegiance (Munder, Fluckiger, Gerger, Wampold, 
& Barth, 2012).  
In conclusion, the utility of randomized placebo-controlled trials in clinical research "to sort therapeu-
tic wheat from chaff" (Jones & Podolsky, 2015, p. 1502) is not unequivocally warranted in psycho-
therapy. Given that placebo conditions in psychotherapy cannot be blinded, the main principle of ran-
domized placebo-controlled trials, i.e. to employ different interventions with the same rationale – or 
put otherwise: to control the incidental, while manipulating the characteristic treatment constituents – 
is not applicable. However, the strive for specificity – understood here as the identification of charac-
teristic treatment constituents outperforming incidental ones – is important regardless of both the un-
derstanding of psychotherapy or of the respective characteristic treatment constituent under investiga-
tion.  
Here, placebo research designs could come to aid. Using a topsy-turvy approach with regard to ran-
domized placebo-controlled trials, the aim is to control for characteristic, while manipulating inci-
dental treatment constituents. A stringent implementation of this approach is the open versus hidden 
design, where an otherwise identical intervention is given to subjects either knowing or not knowing 
when or if the drug will be administered or withdrawn. Differences between conditions are then un-
derstood as placebo-like effects, since the intervention itself is not a placebo (e.g. Lund, Vase, 
Petersen, Jensen, & Finnerup, 2014). This trial design has the merits of being able to specify effects of 
assumingly incidental treatment constituents, e.g. therapeutic meaning (Moerman & Jonas, 2002), 
from those of characteristic treatment constituents without the use of a placebo condition and thus has 
successfully been used in non-pharmacological interventions (e.g. Crum & Langer, 2007; Desharnais, 
Jobin, Cote, Levesque, & Godin, 1993). However, it has not been tested in the realm of psychotherapy 
interventions. Employing an online expressive writing intervention, we tested the feasibility of an 
open/hidden paradigm in psychotherapy and whether the effects of the assumingly characteristic 
treatment constituent of expressing emotions about a traumatic experience are influenced by the as-
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sumingly incidental treatment constituent of providing a therapeutic rationale, i.e. a meaning (Frank, 
1986).  
METHOD 
Design 
We conducted a randomized controlled trial with three experimental conditions in healthy subjects. 
Two groups underwent a standardized online intervention, whereas the control group did not receive 
an intervention. While both intervention groups received the same online intervention, they were given 
different treatment rationales for the intervention: Participants in the causality group were told that the 
intervention will have beneficial effects on mood in the long-run, participants in the reversed causality 
group were instructed that mood will influence how they will perform in the intervention (see Appen-
dix for details).  
The intervention consisted of an online version of the expressive writing paradigm (Pennebaker & 
Beall, 1986), due to its feasibility and proven efficacy to reduce distress in healthy student and clinical 
populations (e.g. Baikie, Geerligs, & Wilhelm, 2012; Beyer et al., 2014). It needs to be noted that ex-
pressive writing leads to short-term deterioration of affect, followed by long-term increase in well-
being (Sloan & Marx, 2004). Subjects in both intervention groups wrote about their most traumatic 
experience on three consecutive days for 20 minutes on each day.  
Procedures  
In total, participants were imbedded in the study for 46 days. The study encompassed three interven-
tion days (days 1 to 3) and four assessments (days 1, 4, 10 and 46 or baseline, post intervention, mid-
term and long-term follow-up, respectively). On intervention and assessment days participants re-
ceived an email with an individual access code for a webpage differing in content according to group 
assignment and study day. For all groups, the website contained the outcome (PANAS, see below). On 
the intervention days, the website also contained an embedded video for the two intervention groups, 
showing a professional speaker explaining the rationale of the intervention. While the instruction was 
equal for both intervention groups in terms of structure and format, the treatment rationale, i.e. pro-
posed meaning, differed in content between these groups (see Appendix for details). For the control 
group, this website contained the outcome only. On intervention days, participants of the intervention 
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groups completed the outcome before and after the expressive writing intervention, while the control 
group completed the outcome only once on each of the intervention days. The intervention, the differ-
ent instructions as well as the assessments were conducted online in order to control for patient-
therapist interaction. Participants were not informed about the existence of and the difference between 
the three groups. Subjects were debriefed after study participation. Participants were provided with 
written information about the study and written informed consent to participate in this study was ob-
tained online and stored digitally. The protocol and consent procedure was approved by the institu-
tional review board of the Department of Psychology of the University of Basel. The trial was not 
registered in a WHO approved registry before enrolment, because the trial initially was not considered 
to qualify as a clinical trial and comparable trials have not been registered as clinical trials (e.g. 
Langens and Schüler, 2005, 2007; Baikie et al., 2012; Beyer et al., 2014). However, the study was 
retrospectively registered at the German Clinical Trials Register (Identifer: DRKS00009428). The 
authors confirm that all ongoing and related trials for this intervention are registered. There were no 
changes to methods after trial commencement. 
Measures 
Possible effects of the experimental conditions were repeatedly assessed for up to 46 days after base-
line with the Positive and Negative Affect Schedule (PANAS, Krohne, Egloff, Kohlmann, & Tausch, 
1996), which was a priori defined as the primary outcome. The PANAS contains two scales with 
overall 10 five-point items assessing positive (e.g. "interested", "proud") and negative affect (e.g. "up-
set", "ashamed"). The internal consistency estimate of reliability for the PANAS scales in the total 
sample was good (positive affect: Cronbach’s alpha=0.87, negative affect: Cronbach’s alpha= 0.79). 
In the intervention groups, linguistic content of written text, subjective rating of the severity of the 
reported traumatic experiences and the plausibility of their respective treatment rationale were em-
ployed to assess the validity of the intervention and experimental manipulation of treatment rationale. 
The linguistic content of the written text was analyzed with Linguistic Inquiry and Word Count, which 
quantifies words in a given text according to preset categories with a 70-80% hit rate (Wolf et al., 
2008). For the purposes of this study, we used the word count of first person singular personal pro-
nouns (e.g. I, me, mine), of negative and positive emotions (e.g. sad, hate, worthless and happy, pretty, 
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good), of cognitive processes (e.g. distinguish, because, know), of causality (e.g. argument, influence, 
effect) and of insight (e.g. recognize, conscious, decision). Subjective rating of the severity of the 
traumatic experiences was assessed with a single sentence 5-point item (i.e. In general, how distress-
ing is the experience you have just written about for you?) and plausibility of the treatment rationale 
was operationalized with a 5-point item for each group (causality group: Writing about a traumatic 
experience influences my well-being, reversed causality group: My well-being influences how I write 
about a traumatic experience). All described measures were assessed online and stored in internal and 
secured data carriers. 
Subjects 
Subjects were recruited amongst psychology students at two Swiss Universities (University of Zurich 
and University of Basel) through mailing lists and web postings at both universities. Inclusion criteria 
were (1) ages of 18 years and older, (2) absence of any mental disorder by self-report, (3) not receiv-
ing psychological or psychiatric or medical treatment in the last six month by self-report and (4) a 
Toronto Alexithymia Scale score below 54 (Kupfer, Brosig, & Brahler, 2000), since alexithymia has 
been shown to influence effects of expressive writing (Paez, Velasco, & Gonzalez, 1999). Of 183 en-
rolled subjects, 19 did not fulfill inclusion criteria and were therefore excluded. A total of 164 subjects 
were randomly assigned to the three experimental groups and 112 participants completed the interven-
tion and all assessments. Random allocation sequences were achieved with individual assignment 
codes in separate envelopes, opened by study personnel after confirmation of eligibility and informed 
consent. Eight subjects dropped out after randomization and before post-intervention assessment and 
30 subjects were excluded due to low commitment in the expressive writing task, defined as writing 
for less than 15 minutes on intervention days by self-report, so that overall 126 subjects were consid-
ered per protocol (control group N=55, causality group N=36, reversed causality group N=35). Fur-
thermore, 14 subjects did not complete all assessments after post-assessment, so that two samples 
were analyzed (completers N=112 and ITT N=126, see Figure 1). Subjects not meeting inclusion crite-
ria as well as those excluded due to low commitment, i.e. not being considered as per protocol, did not 
differ significantly in any baseline demographic or baseline parameters (all p>0.40). Mean age of par-
ticipants was 23 years and 8 months (control group 22 years and 9 months; causality group 24 years 
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and 11 months; reversed causality group 23 years and 11 months) and the gender ratio was 86 women 
and 26 men (control group 37/11; causality group 25/7; reversed causality group 24/8). Overall, only 2 
participants (1.8%) kept a regular diary. Participants received study credits for their participation. The 
flow of participants through the study is shown in Figure 1.  
Data analysis 
Based on assumed small to medium effects of our experimental manipulation of treatment rationale on 
intervention effects, a priori sample size calculation with the statistical software G*Power 3.1 (Faul, 
Erdfelder, Buchner, & Lang, 2009) led to an optimal sample size of N = 120 (f= 0.2, 80% power, 5% 
alpha error, 3 groups, 4 assessments and correlation among repeated measures = 0.3). We assumed 
that our restrictive exclusion criteria, the population under investigation and the emotionally demand-
ing task would lead to a substantial dropout of at least 30%. We therefore set out to recruit N=180. 
SPSS 21 statistical software (SPSS, Chicago, Illinois, USA) for Apple OS X was used for all statistical 
analyses. Analysis of variance or chi-square tests were used to examine demographic and clinical vari-
ables at baseline. A time by group by scale multivariate analysis of variance with subsequent time by 
group univariate analysis of variance for single PANAS scales was used to investigate differences 
between groups regarding treatment effects over time. For significant results between groups, Cohens 
f (calculated from SPSS partial eta-squared with the program G*Power 3.1: 0.1=small, 0.25=medium 
and 0.45=large) was used for time by group interaction effects. Within- and between-group effect siz-
es were calculated using Cohen's d (0.2=small, 0.5=medium, 0.8=large). All results are displayed as 
mean values and standard deviation unless otherwise indicated. All analyses were performed on per 
protocol subjects, i.e. with sufficient commitment in the writing task- All analyses of on protocol sub-
jects were performed on an intent-to-treat (ITT) basis including randomized protocol subjects with 
baseline and at least post-intervention values (day 4) for the variable being analyzed (see Figure 1).  
 
RESULTS 
Characteristics of participants and validation check of intervention 
Experimental groups did not differ significantly regarding gender distribution (female/male: causality 
group: 25/7, reversed causality group: 24/8 and control group: 37/11, chi-square=0.09, p=0.96, age 
 9 
(F(2/109)=1.2, p=0.32), baseline PANAS scores (Table 3, F(4/218)=0.3, p=0.88) and Toronto Alexi-
thymia Scale total score (F(2/109)=1.5, p=0.22; control group: 38.0 (6.9), causality group: 38.6 (6.3) 
and reversed causality group: 35.9 (6.0)). Further, intervention groups did not differ substantially in 
linguistic content of written texts during the three intervention days, but participants in the reversed 
causality group used more first person singular personal pronouns in comparison to participants in the 
causality group on the first intervention day (Table 1). The causality and reversed causality groups 
reported comparable severity of the traumatic experiences on all three days and did not differ substan-
tially in their ratings of the plausibility of treatment rationale (Table 2). The mean number of reported 
experienced traumatic events or troubling issues during the three intervention days was 1.9 (0.9) (one 
event: N=28, two events: N=17 and three events: N=19). The three most prevalent topics were: Death 
or severe illness of family members (e.g. cancer of father, 25%), parental relationship problems (e.g. 
divorce of parents, 22%) and personal relationship problems (e.g. adultery of spouse, 18%).  
 
Insert tables 1and 2 here 
 
The expressive writing intervention led to significant decreases in positive as well as significant in-
creases in negative affect (pre-post time effect: F(2/61)=15.7; p<0.001, f=0.72, Table 3), which both 
gradually attenuated over time (intervention day by pre-post interaction effect F(4/248)=4.5, p=0.002, 
f=0.27). Both intervention groups did not differ in their change of affect following the intervention 
(pre-post by group interaction effect: F(2/61)=0.4, p=0.66). Since participants in the control group 
were not subjected to the expressive writing intervention and thus a pre- and post-assessment on each 
day was not feasible, single assessments of the PANAS on days 1 to 3 were performed and compared 
with pre-intervention scores of the two intervention groups using a repeated multivariate analysis (Ta-
ble 3).The PANAS scores in the control group did not change over time (F(4/188)=0.9, p=0.45). 
 
Insert Table 3 here 
 
Effects of the experimental manipulation 
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To test for possible effect of our experimental manipulation of the treatment rationale in the expressive 
writing intervention, short-, mid- and long-term effects were examined using repeated multivariate 
analyses between all three groups.  
To assess short-term effects, differences in PANAS scores between day 1 (pre-assessment) and day 4 
(1 day post-intervention) were calculated for the three groups. There was no change in PANAS scores 
over time (time effect: F(2/108)=0.5, p=0.60) or between groups (time by group interaction effect: 
F(4/218)=0.2, p=.94). To assess mid-term effects, group differences between day 1 to day 10 (7 days 
post-intervention) were calculated. Again, there were no changes in PANAS scores over time (time 
effect: F(2/108)=0.2, p=0.80) or between groups (time by group interaction effect: (F(4/218)=0.1, 
p=98). However, regarding long-term effects, differences in PANAS scores between day 1 to day 46 
were significant (time effect: F(2/108)=3.3, p=0.04, f=0.25) and groups differed in the long-term 
changes of positive and negative affect (time by group interaction effect: F(4/218)=2.9, p=0.02, 
f=0.23). Significant group differences were found for both positive (F(2/108)=3.6, p=0.03, f=0.25) and 
negative affect (F(2/108)=4.2, p=0.02, f=0.27; see Figure 2). Post-hoc univariate comparisons on 
PANAS scores on day 46 indicated that with regard to positive affect, interventions groups did not 
differ significantly from each other, but both differed significantly from the control group (causality 
group vs. control group: F(1/78)=4.2, p=0.04, f=0.23; reversed causality group vs. control group: 
F(1/78)=4.6, p=0.04, f=0.24; causality group vs. reversed causality group: F(1/62)=0.02, p=0.98). 
With regard to negative affect the reversed causality group did not differ from the control group, but 
both groups differed from the causality group (causality group vs. control group: F(1/78)=4.6, p=0.04, 
f=0.24; reversed causality group vs. control group: F(1/78)=0.03, p=0.88; causality group vs. reversed 
causality group: F(1/62)=4.0, p=0.05, f=0.25). Standardized mean differences for significant effects 
were of small to medium size for positive affect (standardized between-groups differences at follow-
up: causality group versus control group, d=0.49; reversed causality group versus control group, 
d=0.50; standardized within-group baseline to follow-up differences: causality group, d=0.55; reversed 
causality group, d=0.37;control group, d=0.01) and for negative affect (between groups at follow-up: 
causality group versus control group, d=0.57; causality group versus reversed causality group, d=0.64; 
 11 
standardized within group baseline to follow-up differences: causality group, d=0.44; reversed causali-
ty group, d=-0.22;control group, d=-0.19). 
 
Insert Figure 2 here 
Analyses on ITT sample 
Results of analyses on participants who were on treatment and completed at least the day 4 (post-
intervention) assessment did not differ from the completers sample with regard to sample characteris-
tics of participants, validation check of intervention as well as the magnitude of the short- and mid-
term changes of PANAS scores between groups (data not shown). Also, the results for the long-term 
data of ITT sample was comparable to those of the completers sample, with minor changes of type one 
error for the time effect for PANAS scores and group by time interaction effect for positive affect. 
Repeated multivariate analysis of group differences in PANAS scores from day 1 to day 46 indicated 
that PANAS scores changed over time (time effect: F(2/122)=2.7, p=0.07, f=0.21) and that groups 
differed in the long-term changes of positive and negative affect (time by group interaction effect: 
F(4/246)=3.3, p=0.01, f=0.23), with group differences with regard to positive (F(2/122)=2.8, p=0.06, 
f=0.21) and negative affect (F(2/122)=4.7, p=0.01, f=0.28). Post-hoc univariate comparisons of 
PANAS scores on day 46 indicated that with regard to positive affect, interventions groups did not 
differ from each other, but both differed from the control group (causality group vs. control group: 
F(1/88)=4.2, p=0.04, f=0.21; reversed causality group vs. control group: F(1/82)=3.6, p=0.06, f=0.2; 
causality group vs. reversed causality group: F(1/68)=0.02, p=0.97). With regard to negative affect the 
reversed causality group did not differ from the control group, but both groups differed from the cau-
sality group (causality group vs. control group: F(1/88)=6.3, p=0.01, f=0.27); reversed causality group 
vs. control group: F(1/82)=0.5, p=0.51; causality group vs. reversed causality group: F(1/68)=9.6, 
p=0.003, f=0.37). Standardized mean differences for significant effects in the ITT sample were of 
small to medium size for positive affect (standardized between-groups differences at follow-up: cau-
sality group versus control group d=0.41; reversed causality group versus control group d=0.43; stand-
ardized within-group baseline to follow-up differences: causality group d=0.46; reversed causality 
group d=0.30;control group d=0.01) and for negative affect (between groups at follow-up: causality 
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group versus control group, d=0.57; causality group versus reversed causality group, d=0.64; standard-
ized within group baseline to follow-up differences: causality group, d=0.33; reversed causality group, 
d=-0.28;control group, d=-0.2). 
 
DISCUSSION (WORD COUNT: 1174) 
The aim of this randomized-controlled trial was to test the feasibility of an open/hidden paradigm in 
psychotherapy research and to assess the effect of the assumingly incidental treatment constituent of 
providing a treatment rationale to the assumingly characteristic psychotherapeutic intervention of ex-
pressive writing.  
First, both the intervention as well as the experimental manipulation proved to be valid and feasible, as 
indicated by the linguistic content analysis, the expected detrimental effects of expressive writing on 
affect during intervention days and participants rating of plausibility of their treatment rationale. 
Noteworthy, intervention groups did not differ in these parameters, so that it is unlikely that observed 
effects of the experimental manipulation of the treatment rationale are the consequence of differences 
in the perception, implementation and direct effects of the intervention itself. Second, while the exper-
imental manipulation did not influence affect in short- and mid-term, we observed significant long-
term differences between groups. Both intervention groups reported higher positive affect six weeks 
after the intervention in comparison to the no-treatment control group. In contrast, while the causality 
group showed a decrease of negative affect, the reversed causality group did not seem to benefit from 
the intervention in the same fashion. All of these group differences were of medium effect size and the 
differences between the reversed causality and causality group in negative affect at follow-up exceed-
ed the magnitude of observed within group-changes between baseline and follow-up.  
In the following, the observed effects will be discussed from an expressive writing, a theoretical and a 
methodological perspective. With regard to the former, the results of the causality group followed the 
expected direction and time course, with a temporally delayed and medium-sized improvement in 
affect (e.g. Langens and Schüler, 2005, 2007; Beyer et al., 2014). Also, immediate deterioration of 
affect with long-term improvement is proposed as the normal psychokinetic of expressive writing 
interventions (Baikie et al., 2012) and follow-up duration has been found to be a significant predictor 
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of expressive writing effects, with longer-term follow-up studies showing better outcome than studies 
with shorter-term follow-up (Travagin, Margola, & Revenson, 2015). It needs to be noted that alt-
hough the observed effects are comparable to previous publications (see above), our trial is at best 
considered an efficacy trial and thus our results do not shed light on the effectiveness of online expres-
sive writing interventions. 
From a theoretical perspective, the observed response differences between the intervention groups are 
per se not unexpected. For example, a recent within-subject randomized blinded balanced placebo 
design observed higher analgesic effects with overt in contrast to covert lidocaine injections in healthy 
subjects (Lund et al., 2014). Similarly, providing an otherwise similar aerobic exercise training or a 
work-related behavior with group-specific therapeutic rationales led to larger changes in self-esteem 
(Desharnais et al., 1993) or physiological health parameters (Crum & Langer, 2007), respectively. 
However, it needs to be noted that the reversed causality group benefitted from the intervention with 
regard to positive, but not to negative affect. Here, an early study on the effects of either open or hid-
den administration of a pharmacological intervention is informative. Ross et al. (1962) observed dis-
comfort in subjects receiving 10 mg of d-amphetamine covertly, while the overt administration result-
ed in neutral to comfortable mood, arguing that subjects who covertly received the pharmacological 
intervention, "had no 'therapeutic' set and presumably reported their feelings 'honestly' on the mood 
scales" (Ross et al., 1962, p. 391). However, the processes underlying the observed differences, such 
as differences in experiencing or attributing symptoms or both, need to be elucidated in further studies,  
Regarding the methodological approach, the observed effects of our trial support the feasibility and 
utility of an open/hidden administration to disentangle effects of incidental treatment constituents from 
those of characteristic treatment constituents. In this regard, the beneficial effects on positive affect in 
both intervention groups could be seen as being caused by characteristic constituents of expressive 
writing, while the incidental treatment constituent of providing a treatment rationale is needed to ob-
tain full effects, i.e. beneficial changes in both positive and negative affect. It needs to be noted that 
the definition of what is to be considered characteristic or incidental in psychotherapy is complicated 
by the fact that many treatments include the provision of a treatment rationale without defining its role 
in the treatment theory as characteristic. While this in general highlights the need to revise treatment 
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theories (Gaab et al., 2015), the definition of what is to be considered incidental or characteristic in the 
case of expressive writing was considerably facilitated by the fact that the original instruction (Penne-
baker, 2000) did not contain the provision of a treatment rational and thus is clearly considered inci-
dental to the treatment. According to Grünbaum's conceptualization (1981), a treatment qualifies as 
verum2 when at least one characteristic treatment constituent is therapeutic for a given disorder. With 
regard to our findings, we have reason to assume that expressive writing qualifies as verum, since its 
effects are observable even when administered covertly. However, there is an important amendment to 
this conclusion. Explanatory models and theories of expressive writing currently focus on emotion-
related processes, i.e. propose disinhibition, emotional catharsis, cognitive-processing, self-regulation, 
exposure, social integration or development of a coherent narrative as underlying principles of change 
(Baikie et al., 2012; Frattaroli, 2006). Based on our results and given that 1) expressive writing effects 
are strongly associated with positive response expectancies, 2) a full confrontation with the traumatic 
experience is not a prerequisite for these effects (Langens & Schuler, 2007) and 3) that writing about 
traumatic events is as beneficial as writing about positive events (Frattaroli, 2006), future research is 
warranted to elucidate characteristic treatment constituents in expressive writing and to revise the un-
derlying treatment theory accordingly.  
There are several aspects of our study that need to be considered critically. First, participants in the 
reverse causality group may have known about the beneficial effects of writing. However, controlling 
for this is difficult, if not impossible, as asking participants about their assumptions regarding possibly 
positive effects of writing might itself provoke or prime such assumptions. Therefore, we opted 
against a direct inquiry and instead assessed the plausibility of the respective condition rationale., Our 
results showed no difference between the intervention groups, which indicates that participants found 
both possible causal directions between affect-change and writing equally acceptable. Second, we 
experimentally manipulated the treatment rationale and thus provided the causality group, i.e. the open 
administration of the intervention, with a description of expected positive effects of the intervention. 
In the original instructions (e.g. Pennebaker, 2000) this clear description and direction of effects is 
missing. However, the therapeutic properties of expressive writing interventions are inherently tied to 
                                                       
2 Which he chooses to label "non-placebo" 
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accounts of this intervention (e.g. Pennebaker, 2011) and even with the original instructions, i.e. with-
out providing a description of expected positive effects, high positive expectancies that the writing 
intervention will have beneficial effects were found in comparable populations (Langens & Schuler, 
2007). Also – at least with respect to ethical guidelines in psychotherapy – providing a treatment ra-
tional is integral to normative guidelines (see Blease et al., 2016). Since our aim was to test the effects 
of an experimental manipulation of providing a treatment rationale (and not to replicate the effects of 
the original expressive writing instructions), we choose to make the implicit explicit, by providing and 
manipulating the rationale of the two conditions.  However, it needs to be acknowledged that our in-
structions differed from those in Pennebaker (2000), which did not provide a description of any antici-
patory effect or treatment rationale. Third and closely related to the previous aspect, our hidden ad-
ministration of the online expressive writing intervention differs from similar approaches in medical 
research, where the patient is unaware when a given substance is administered. Instead, we operation-
alized the hidden administration by providing an alternative non-therapeutic rationale to ensure that 
both experimental conditions do not differ in their credibility and to minimize the possibility that the 
expressive writing intervention would per se be perceived as therapeutic. Given that this has been ob-
served in trials not providing a rationale (e.g. Langens & Schüler, 2007), we addressed this problem 
by implementing a non-therapeutic rationale. Finally, it needs to be noted that we carried out a large 
number of analyses and thus there is a probability that our main finding is due to chance. However, it 
needs to be considered that 1. we carefully analyzed pre-defined hypotheses with multivariate meth-
ods, 2. our finding of a significant short-term deterioration and a long-term improvement replicates 
previous findings on expressive writing from independent groups and 3. our main finding of a signifi-
cant group difference in the course of long-term negative affect is of medium effect size and the con-
sequence of a well-controlled experimental design. Therefore, we consider the probability of a chance 
finding as minimal 
To conclude, we consider the manipulation of assumingly incidental treatment constituents while 
keeping assumingly characteristic treatment constituents constant, as a promising design for psycho-
therapy research. Although our study might also illustrate the difficulties of this approach, it is far 
from new. Faced with the problem of an effective treatment without a proven mechanism, Benjamin 
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Franklin and colleagues employed probably the first documented open/hidden trial to test Anton 
Mesmers animal magnetism at the end of the 18th. century. Using a specially designed blindfold, the 
servant of an experienced practitioner of magnetism was put to test: "Magnetized next with eyes un-
covered, he feels tingling in his forehead when the metal rod is brought close to it; blindfolded again, 
he feels no tingling when the rod is brought close" (cited from Franklin et al., 2002; p. 347). These 
results, amongst others, convinced the Franklin commission that "having finally demonstrated by deci-
sive experiments that the imagination without magnetism produces convulsions, & that magnetism 
without imagination produces nothing" or state otherwise, that the otherwise impressive effects of 
magnetism was fully driven by its incidental and not by any characteristic treatment constituents.  
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